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Abstract
This thesis reports an investigation of the uptake of Li+ into human 
erythrocytes using quantitative 7u-nmr spectroscopy. It was found that the 
erythrocytes of psychiatric patients, who were on long term lithium therapy 
for the treatment of bipolar affective disorder, accumulated more Li+, and 
attained an apparent steady-state concentration more rapidly than did the 
erythrocytes of healthy controls, not taking lithium. This phenomena was 
shown to be due, at least in part, to a Li+-induced effect resulting from the 
treatment of these patients with Li+. Indeed, prior to treatment the uptake of 
Li+ into the erythrocytes from all the patients was similar to that in the 
erythrocytes of the healthy controls. This Li+-induced effect is consistent with 
the inhibition of the Na+-Li+ countertransport mechanism, the predominant 
Li+ efflux pathway in erythrocytes, which has previously been shown to be 
inhibited by Li+.
The uptake of Li+ into cultured cells was also monitored by ^Li-nmr 
spectroscopy, by growing the cells upon the surfaces of microcarrier beads. 
Excellent spectra were obtained from which the uptake of Li+ was found to 
be approximately ten-fold faster than that into erythrocytes, with the steady- 
state being achieved more rapidly.
In an attempt to rationalise the altered transport behaviour of 
erythrocytes exposed to Li+ in vivo, the effect of this cation upon the major 
components of the erythrocyte membrane were investigated by TLC and gel 
electrophoresis. However, no significant differences were observed in either 
the relative amounts of the lipids, or in the major protein content of the 
erythrocyte membranes from Li+-treated patients and from healthy controls 
not taking lithium.
^Li-nmr spectroscopy w as also employed to investigate the 
interaction between Li+ and the enzyme, inositol m onophosphatase, 
however under the conditions of the experiment no interaction was 
observed.
Finally, a  brief study of the transport behaviour of the Cs+ ion across 
the human erythrocyte membrane using i33Cs-nm r spectroscopy is 
reported. The uptake of Cs+ into the erythrocytes of patients suffering from 
alcohol-dependence syndrome, the erythrocytes of whom are reported to 
contain abnormally high levels of Cs+, was found to be virtually identical to 
that of abstinent controls.
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Chapter 1
Introduction
1 .1  Introduction
In recent years, considerable success has been achieved using nuclear magnetic 
resonance spectroscopy to study the lithium ion in biological systems, with the 
intention of probing the possible mechanisms of action of this cation in psychiatric 
therapy. This thesis is primarily concerned with the use of high-resolution, nuclear 
magnetic resonance spectroscopy to study the lithium ion in cell systems, in particular 
to investigate the effect of lithium therapy on the transport of the lithium ion in human 
erythrocytes. The effect of the lithium ion on membrane composition, using 
chromatographic techniques, and the interaction of the lithium ion with the enzyme 
inositol monophosphatase, using nuclear magnetic spectroscopy, are also investigated. 
Finally, a preliminary study on the transport behaviour of the caesium ion in human 
erythrocytes is discussed.
In this chapter, following an introduction to the medical applications of lithium, 
the membrane transport behaviour of the lithium ion is described and then the 
application of the high-resolution nuclear magnetic resonance spectroscopy of the alkali 
metal ions to biological research is discussed.
1 .2  Lithium in Medicine
Throughout history many theories concerning the therapeutic qualities of the 
lithium ion have been proposed covering a wide range of illnesses, including gout, 
gallstones, rheumatism and eczema. For one reason or another, most of these claims 
have now been discredited. However, the therapeutic effect of lithium salts in the 
treatment of bipolar affective disorder has been confirmed and they are now the 
treatment of choice for the control of acute mania and in the relapse-prevention of 
bipolar affective disorder. Currently, approximately 1 person in 1000 in the UK is 
receiving lithium therapy. A significant amount of research is also underway into the
efficacy of lithium salts for the treatment of other disorders, such as schizophrenia, 
alcoholism, aggression, premenstrual tension and epilepsy. In addition, topical 
applications of lithium salts have been shown to be clinically effective in the treatment 
of a number of inflammatory skin disorders, including seborrhoeic dermatitis and 
herpes.
1.2 ,1  Psychoses
The most common forms of psychoses in man are schizophrenia and manic 
depression, and both of these illnesses flare up episodically. Patients suffering from 
manic depression often experience periods of relative normality between the episodes of 
affective illness. Schizophrenia takes a more deteriorating course and people suffering 
from this illness lose contact with reality, suffering delusions and hallucinations.
1 . 2 .2  Affective Disorders
The affective disorders are illnesses which affect the mood of a person and are 
divided into two categories: bipolar affective disorder and unipolar affective disorder. 
People suffering from bipolar affective disorder, also known as manic-depressive 
illness or bipolar II, experience recurrent episodes of both mania and depression 
whereas people suffering from unipolar disorder, also referred to bipolar I, experience 
the depression but not the mania. The term 'schizoaffective disorder' has also been 
employed where there is an apparent co-existence of manic and schizophrenic 
symptoms in a patient.
In bipolar affective disorder, the periods of mania and depression occur in either 
regular or irregular sequences. Some patients experience swings in mood on a daily 
basis but more often the episodes of mania and depression are less frequent and less
regular, with intervening periods of normal mental function. During a manic phase the 
patient is in a state of overexcitement and is characteristically elated, hyperactive, 
excessively self-confident, talkative, aggressive, over-indulgent and impulsive. 
Conversely, the depressive phase of the illness is characterized by sadness, inactivity, 
indecision, low self-esteem and suicidal thoughts. In some cases a person suffering 
from bipolar affective disorder may experience only a few episodes of illness during 
their lifetime.
1 .2 .3  Lithium in Psychiatry
In 1949, it was discovered that the salts of lithium had therapeutic properties in 
some types of psychiatric illness (1). The discovery of the therapeutic effects of the 
lithium ion, Li+, was totally unexpected since it was actually the toxicity of urea and 
uric acid which was under investigation at that time. It had been proposed that people 
experiencing acute mania excreted higher levels of uric acid in their urine than did 
normal controls and, on this basis, a series of animal experiments were performed 
involving the administration of injections of mixtures of urea and lithium urate to guinea 
pigs, the lithium ion being chosen because of its ability to dissolve uric acid. The 
predicted toxicity with the urate salts was not observed, however the researchers were 
surprised to discover that the animals had lost their usual timidity; they did not become 
distressed when handled and were generally very lethargic. Further investigation 
showed that this effect was caused by Li+ alone. After administration of lithium 
carbonate and lithium citrate to healthy humans, the salts were then given to a number 
of patients suffering from mania, schizophrenia and chronic depression (1). The manic 
patients all showed a significant and rapid improvement. These results led to a number 
of other studies showing similar positive results for manic patients. However, at about 
the same time, the severe side effects which occurred in a totally separate use of lithium 
salts, including several fatalities, when LiCl was substituted for NaCl in the diet of
patients suffering from cardiovascular illnesses or hypertension, gave lithium salts a 
bad reputation which naturally resulted in a severe restriction of their use in the clinic 
and of the necessary research (2). Thus the initial acceptance of lithium therapy was 
slow and controversial.
Li+ has been shown to exert its therapeutic effect against mania and, to a lesser 
extent, against depression in bipolar affective disorder. However, the main use of Li+ 
is in relapse-prevention of both the manic and the depressive episodes with the same 
efficacy, in bipolar and unipolar affective disorders (3). Treatment with Li+ usually 
produces an attenuation of the manic and the depressive recurrences. In healthy 
individuals and in bipolar patients commencing Li+ therapy during the interval between 
psychotic episodes, there is surprisingly very little effect on normal mood and cognitive 
functions. Li+ is not effective in all cases; 1-2% of bipolar patients and approximately 
20% of manic patients fail to respond to treatment with Li+. In addition, the 
effectiveness of Li+ in the treatment of a number of other disorders has been reported, 
including acute depression (both bipolar and unipolar), schizoaffective disorder, 
schizophrenia, alcoholism and aggression. Further medical applications of lithium salts 
under investigation include: herpes simplex virus, aplastic anaemia, headaches, 
premenstrual tension, hyperthyroidism, granulocytopenia, Menieres syndrome and 
AIDS.
1 . 2 . 4  Li+ Medication
Li+ salts are predominantly administered in tablet form. The carbonate is the 
most convenient, and hence the most common salt of Li+ employed and its extensive 
use has shown no problems specific to this salt. In contrast, the citrate contains a lower 
proportion of Li+ and hence more drug has to be administered for the same clinical 
response, however the taste of lithium citrate is more acceptable and it is commercially
available in syrup form. Other salts, such as the sulphate and the acetate, are also 
commercially available although the chloride is far too deliquescent for convenient use.
Sustained-release formulations of lithium carbonate have been designed to 
modify the rate of release of Li+ and thus lower the rate of absorption of Li+, in order 
to reduce the frequency and the intensity of the side effects. However, in a comparison 
of the pharmacokinetics of a sustained-release and a standard-release formulation, no 
significant differences were found in either the maximum Li+ concentrations in the 
serum or in the time that this peak occurred (4).
The nature of the clinical response and the intensity of the side effects upon 
patients as a consequence of lithium therapy is related to the concentration of Li+ in the 
blood plasma. A significant increase in toxic side effects with no corresponding 
increase in efficacy is observed above a plasma level of approximately 1.4mM, 
however below 0.4mM the drug is ineffective. Thus, Li+ has a very narrow 
therapeutic window, with a tenuous balance between its therapeutic efficacy and the 
unwanted side effects. Therefore, monitoring of plasma Li+ levels, particularly during 
the initial stages of treatment is necessary to ensure a safe and effective dose is 
administered to the patient. It is now standard practice to monitor the levels of Li+ in 
the blood plasma of patients 8-12 h after the last dose. The recommended range varies 
between health authorities and countries, but in the UK a range of 0.3 - l.OmM is now 
generally accepted (5). This is achieved by the daily administration of 600-1000mg 
Li2C03 (approximately 15-30mmoles Li+). However, higher levels are sometimes 
required for the relief of acute episodes of mania.
1 . 2 . 5  Side Effects and Toxicity of Li+
Lithium therapy is associated with numerous, relatively common side effects, 
most of which can be alleviated by adjusting the dose administered or sometimes by
switching from standard release to slow release drugs. These side effects occasionally 
occur at acceptable serum Li+ levels indicating an unusual sensitivity to Li+. The 
milder side effects include thirst, polyuria, gastric irritation, weight gain and fine hand 
tremor, whereas more intense effects include nausea, vomiting, diarrhoea, increased 
hand tremor and muscle weakness, trembling, headaches, impaired concentration, 
vertigo, blurred vision and tinnitus, with patients feeling fatigued and lethargic. Cases 
of severe intoxication are characterised by increased cognitive impairment and 
restlessness, slurred speech, and confusion, which can precede brain damage, 
delirium, coma, seizures, and finally death.
Li+ treatment can result in adverse effects upon the thyroid gland - the 
primary effect is the inhibition of hormone release, which reduces the amount of 
thyroxine reaching circulation and consequently some Li+-treated patients develop 
goitre. It has been suggested that the inhibitory effects of Li+ are compensated for by a 
raised secretion of TSH and thus an increase in the stimulation of the thyroid. The 
elevation of thyroid stimulating hormone, TSH, sometimes observed during the early 
stages of Li+ tieatment usually disappears but can occasionally lead to hypothyroidism. 
TSH measurement is the most sensitive commonly available test of thyroid function.
Li+ treatment can lead to precipitation of some skin disorders, such as acne and 
psoriasis. Also, some adverse drug interactions have been observed, for instance with 
diuretics and nonsteroidal antiinflammatory drugs, primarily due to a decrease in the 
efficiency of the renal clearance of Li+ resulting in higher serum levels. ACE inhibitors 
(angiotensin-converting enzyme) may also increase serum [Li+], possibly due to 
inhibition of the formation of angiotensin II, a potent stimulator of thirst, and thus 
leading to dehydration.
Although teratogenesis in animals, as a consequence of Li+ administiation, has 
occasionally been reported, the incidence of foetal abnormality in humans does not 
appear to be higher than normal. However, Li+ does cross the human placenta and the
foetus is exposed to the same concentrations of Li+ as the mother (7), therefore the risk 
of continuing Li+ treatment during pregnancy should be weighed against the risk 
involved by stopping the therapy and the likely return of the previous psychiatric 
disorder.
1 .3  Mechanism of Action of Li+
Despite the widespread clinical use of Li+, its mode of action in psychiatric 
therapy remains unknown. It is possible that the answer may not be found until the 
genes responsible for the affective disorders are characterised. Research has uncovered 
numerous biological systems which are influenced by Li+. However, which of these 
effects, if any, are important and how they are involved in the treatment of affective 
disorders is unknown. It may be that a cocktail of several Li+-induced effects is 
responsible for its therapeutic action. The mode of action needs to account for both the 
acute and the prophylactic efficacy in mania and depression, and for the slow onset of 
its effectiveness.
Li+ effects have been demonstrated on membrane transport systems, cyclic 
AMP-dependent systems, phosphoinositide metabolism, viral replication and 
prostaglandin synthesis. In some of these effects Li+ appears to compete with Mg^+, a 
cofactor for many enzymes.
Li+ clearly affects the second messenger systems, inhibiting stimulated 
adenylate cyclase leaving basal activity unaltered, and inhibiting stimulated 
phosphoinositol turnover leaving basal activity unaltered. Many hormones and 
neurotransmitters exert their effect by stimulating the synthesis of cyclic AMP. 
Adenylate cyclase activity, stimulated by such an agonist, is mediated by a 
Mg^+-dependent, guanine nucleotide-binding protein. It has been shown that Li+ 
interferes with the binding of the G-protein resulting in an inhibition of accumulation of
cyclic AMP (8). The effect of Li+ on the phosphoinositide-dependent signalling system 
is discussed in Chapter 6.
Li+ interferes with the biosynthesis of prostaglandins by inhibiting the 
cyclooxidation of the fatty acids - Mg^+ is a cofactor in the cyclooxygenase system (9). 
Manic patients have abnormally high levels of PGEl, thus this inhibitoiy behaviour 
may offer an explanation for the antimanic action of Li+.
Li+ influences a number of cell types in the immune system, stimulating 
protective host responses, and the haemotopoietic system, increasing the production of 
granulocytes and platelets (10). Li+ inhibits DNA synthesis and therefore effectively 
interferes with the replication of DNA viruses. The stimulation of immune responses 
and inhibition of viral replication are responsible for the efficacy of Li+ in the treatment 
of herpes. It appears that Li+ inhibits Type I and Type II herpes simplex viruses. This 
antiviral effect of Li+ has stimulated research of its effects in the treatment of HIV and 
AIDS. In AIDS, it has been shown that Li+ increases the number of T4 helper 
lymphocytes and may also permit patients to receive higher doses of AZT.
A number of enzymes, apart from those involved in the above systems, have 
also been shown to be influenced by Li+, and many of these are Mg2+-dependent. For 
instance, Li+ stimulates Na+/K+-ATPase in a dose dependent manner and inhibits 
pyruvate kinase ( 11).
1.4  Membrane Transport
An essential characteristic of biological membranes is their selectivity in 
permeability with respect to the movement of molecules and ions, thus providing 
environments favourable for the processes required to sustain Ufe. Membrane transport 
mechanisms are responsible for the maintenance of intra-, and extracellular ionic and 
molecular composition and pH, and for the regulation of cell volume. The production
of ion gradients across membranes is essential in cellular systems as the resulting 
electrical potentials are a source of the potential energy required for several functions, 
including the transport of other species. In neurons, for instance, the electrical potential 
derived from trans-membrane ion gradients is involved in the propagation of signals as 
ion currents.
The movement of a substrate across a membrane is a consequence of either a 
passive or an active transport mechanism, and can occur by either a mediated or a non­
mediated process. Non-mediated transport occurs by dissolution of the transporting 
species into the membrane lipids and subsequent diffusion to the other side, the primary 
barrier to diffusion being the hydrophobic lipid core of the membrane. In mediated, or 
facilitated transport, specific proteins within the membrane containing both 
hydrophobic and hydrophilic regions, increase the permeability of the membrane 
towards particular molecules and ions. Specific complexes are formed between the 
transporting protein and the substrate, and conformational changes of the protein are 
often involved during the transport process. At least three steps are involved in the 
mediated transport processes; the formation of a complex between the transporter and 
the substrate; the diffusion across the membrane; and the dissociation of the substrate 
from the transporter at the other side of the membrane. Channel proteins are so called 
because they form hydrophilic channels which span the bilayer of the membrane 
forming an aqueous environment for the diffusion of substrates down the concentration 
gradient. These proteins do not interact strongly with the translocating substrates and 
hence their selectivity arises from the size and charge of the substrates.
The transport of one substrate is often coupled to that of another and, in this 
cases, is described as being either a co-, or a countertransport process. When only one 
substrate is transported the process is termed uncoupled transport, and transport is 
initiated by the formation of the substraterprotein complex.
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The research into membrane transport processes has been facilitated by the use 
of artificial vesicles whose size and composition, with respect to both phospholipids 
and transport proteins, can be strictly controlled to study particular mechanisms. For 
instance, the involvement of ATPase in the Na+/K+ pump was confirmed by observing 
the activity of the pump when the purified protein was inserted into vesicles (12).
Mammalian transport systems involve both facilitative diffusion systems and 
active transport to similar extents; many of these processes appear to be coupled to the 
hydrolysis of ATP or are Na+ symports.
1.4 .1  Free Energy of Transport
The free energy change (AG) involved in the diffusion of a substrate, of charge 
Z, across a membrane, from side 1 where the concentration is to side 2 where the 
concentration is C2, is given by:
CoAG = R T l n ^  + ZFAV (1.1)
where R is the gas constant (8.31JK“lmol"l); T is the temperature (K); F is the Faraday 
(96.48kJV"lmol"l); and AV is the trans-membrane potential difference (V). Obviously 
for uncharged substrates, Z is zero and hence the free energy change for the transport is
Cosimply RT In
1 . 4 . 2  Passive Transport
In passive transport, the change in free energy is negative. The driving force 
for these processes is generally the electrochemical gradient across the membrane; the 
translocating substrate moves from an environment of higher to one of lower
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concentration. The rate of transport is dependent on the permeability of the membrane 
with respect to the substrate.
1 , 4 . 3  Active Transport
In active transport, the change in free energy is positive. An active transport 
mechanism can transport a substrate across a membrane against its electrochemical 
gradient; the energy required for the process is provided by a chemical reaction. The 
most ubiquitous transport process in animal cells is the Na+/K+ pump, an active 
system in which the energy is produced by the hydrolysis of ATP by the enzyme 
Na+/K+-ATPase.
1 . 4 . 4  Cotransport and Countertransport
Co-, and countertransport occur when the transport of one substrate is coupled 
to the movement of one or more other substrates, the driving force usually being the 
electrochemical gradient of one of the substrates. All the substrates must be available 
for transport to occur, however the molecular mechanisms for the transport of each of 
the substrates are not necessarily the same. The transport of the substrates can be either 
simultaneous or sequential, and the stoichiometry of the process is not necessarily one 
to one. A cotransport, or symport, is a system in which the substrates aie canied in the 
same direction, and a countertransport, or antiport, is one in which the substrates move 
in opposing directions across the membrane. The membrane protein responsible for the 
transport is called either a symporter or an antiporter, respectively. In animal cells these 
systems are mostly driven by the trans-membrane Na+ gradients which are maintained 
by the Na+/K+ pump. For example, glucose is actively cotransported into cells by the 
simultaneous entry of Na+ down its concentration gradient.
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1 .5  Li+ in Biological Systems
Li'*' does not normally occur in biological materials and no biological system in 
humans has been shown to be dependent upon this cation. Since there is no 
radioisotope of lithium with a convenient half-life, the main methods for the clinical 
analysis of Li"*" are atomic absorption spectrophotometry (AAS) and flame emission 
spectrophotometry (FES). More recently, nuclear magnetic resonance spectroscopy 
(NMR), ion-selective electrodes (ISE) and neutron activation methods have been 
employed to study Li"** in biological materials (13). Both AAS and FES are susceptible 
to interference from other elements present in the sample and, in the case of biological 
material, the relatively high concentrations of Na"*" and K"*" interfere with the analysis of 
the lower levels of Li"*", and must be allowed for by the use of appropriate standards.
1 .5 .1  Distribution of Li+ in vivo
The hydrated Li"*" ion has the largest effective diameter, lowest diffusion 
coefficient and least lipid solubility of all the alkali metals (14). It might therefore be 
expected that the movement of this cation may be more limited than that of either Na**" 
and K"*" and therefore that the distribution of this cation in vivo may be difficult to 
predict. The atomic and ionic radii of lithium are more similar to those of magnesium, 
and the hydrated radius and electronegativity are more similar to those of calcium than 
to those of sodium. Consequently, it may be that the physiological behaviour of Li"** is 
more like Mg^ "*" and Ca^ "*" than either Na**" or K"*" (15).
The concentration of lithium ions, [Li"*"], in the blood plasma of patients taking 
Li"*" is carefully monitored and maintained in the range 0.3 - l.OmM by adjustment of 
the dose, the blood samples having been taken 12h after the previous dose. During 
lithium therapy, Li"*" is widely, and unevenly distributed throughout the body fluids and 
tissues. In the brain the average [Li"*"] was originally reported to be approximately the
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same as that in the plasma, whereas in the saliva it is about twice as high and in the 
cerebrospinal fluid it is much lower (idj. However, recent preliminary studies using in 
vivo magnetic resonance techniques on living patients, suggest that the [Li+] in the 
brain and muscle are lower than that in the serum (17). Compared to the [Li+] in 
serum, studies on animals have shown higher levels in the kidneys, bone (18), and 
endocrine glands, especially the thyroid (6), and lower levels have been found in the 
liver (19,20). The distribution of Li+ may be due in part to the relative rates of entry 
and efflux in the different tissues. For instance, the uptake of Li+ from the blood is 
rapid into the kidney, is slower into the liver, bone and muscle, and is very slow into 
brain, and it was concluded that the relatively slow uptake into the brain is due to the 
low permeability of the blood-brain barrier (21 ). Lower Li+ uptake rates into the brain 
and muscle compared to serum have also been observed using in vivo magnetic 
resonance studies (22). Table 1.1 shows the post mortem Li+ distribution of a male 
patient who had been on a maintenance dose of 1200mg/day Li2C03 for the treatment 
of manic depression, for three months prior to his death (20).
The distribution of Li+ in different regions of the brain is uneven but no 
particular region appears to accumulate Li+ to any significant extent (20,23). Table 1.2 
shows the result of a post mortem examination of the Li+ distribution in the brains of 
two patients, both of whom had received 900mg/day Li2C03 for the treatment of mania 
for only a few days prior to death. The [Li+] was higher in the pons than in the 
cerebral white or grey tissue or in cerebellar tissue (23). The distribution of %i+ in a 
section of mouse brain has been imaged by a neutron irradiation technique (24). This 
clearly shows a variation in Li+ accumulation, with, for example, higher Li+ levels in 
both the hippocampus and hypothalmus, and a lower level in the thalamus.
1 4
Table 1.1 The distribution of Li+ in man post mortem (mmol. kg~^ ) (20)
TISSUE [Li+]
Whole blood* 0.86
Bile* 7.8
Bone 2.54
Cardiac muscle 1.4
Lymphoid tissue 1.3
Thyroid 1.1
Pituitary 0.9
Kidney 0.9
Lung 0.8
Fat 0.7
Spleen 0.7
Alveolar connective tissue 0.6
Liver 0.4
Testis 0.3
Femoral Nerve 0.2
able 1.2 The distribution of Li+ in human brain (mmol.kg~^)(23)
TISSUE PATIENT 1 PATIENT 2
Serum* 0.25 0.35
Grey Matter 0.15 0.24
White Matter 0.18 0.34
Cerebellum 0.17 0.35
Pons 0.35 0.65
^Values for whole blood, bile and serum are expressed in mM Li+
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1 .5 .2  L i+ Transport in Erythrocytes
Studies of Li+ transport across membranes have predominantly employed 
erythrocytes since these are readily and ethically available, with individual cells freely 
flowing in suspension. If the movement of Li+ across the erythrocyte membrane is 
purely passive, the ratio of the [Li+] in erythrocytes to that in plasma (Li+in /Li+out) 
should reach approximately 1.5 at steady-state in vivo (from equation 1.1, where AV is 
lOmV for erythrocytes). However, during lithium treatment, the actual [Li+] in 
erythrocytes is lower than that in plasma (25), indicating the presence of active 
transport mechanisms which can extrude Li+ from erythrocytes. It has been suggested 
that the concentration of Li+ in erythrocytes or the erythrocyteiserum concentration ratio 
may be correlated with the clinical state or the response to Li+ treatment (26). 
Additionally, the concentration of Li+ in the brain correlates with that in erythrocytes 
better than that in the plasma (27), and some transport processes in erythrocytes are 
qualitatively similar to those in neurons, for example the Na+ZK"*" pump. Thus, the 
transport mechanisms for Li+ operating in erythrocytes have been extensively 
investigated. However, it should be noted that erythrocytes have an atypical 
morphology and no nucleus, compared to most cells.
Five processes which can operate as pathways for the movement of Li+ across 
the human erythrocyte membrane have been elucidated and characterised, and are 
depicted in Figure 1.1: a Na+-Li'*' countertransport, the Na+/K+ pump, a leak’, an 
anion exchange and a Na+-K+ cotransport. These pathways have been characterised in 
vitro by manipulation of the composition of, and by the use of known transport 
inhibitors in the incubating media of suspensions of erythrocytes. The relative 
contribution of each of these processes to the overall fluxes of Li+, both the influx and 
the efflux, is greatly influenced by the composition and pH of the incubating medium, 
in particular with respect to the [Na"**] and [K+]. Under artificial conditions of ion 
concentration, temperature and pH, Li+ can be transported into, or out of eythrocytes 
by any of these mechanisms. However, under pseudo-physiological conditions and at
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extracellular [Li+] typically found in the plasma during lithium therapy (0.3 - l.OmM), 
the transport of Li+ by many of these processes is inhibited. For example, the uptake 
of Li+ into cells by the Na'^/K+ pump is inhibited by physiological concentrations of 
extracellular K+ (28). It is generally agreed that under physiological conditions and, by 
inference, in vivo during lithium therapy, the uptake of Li+ into erythrocytes is 
predominantly by the two passive diffusion processes, the ‘leak" and the anion 
exchange pathway, and that Li+ is actively transported out of the erythrocyte by the 
Na+-Li+ countertransport route. The five Li+ transport pathways are discussed in 
detail below.
Na+-K+ Pump
Na+-Li+
Countertransport
’Leak'
Anion Exchange 
Li+:(C03)^ -
Na -^K'"' Cotransport
Figure 1.1 Transport pathways for Li+ in human erythrocytes
(Li+ can be transported by any of the pathways shown; the bold arrows indicate 
mechanisms operating under physiological conditions)
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The 'leak' is a passive diffusion pathway which transports Li+ into erythrocytes 
down its concentration gradient. The rate of uptake increases linearly with increasing 
extracellular [Li'*'] and for a ImM difference in [Li+j the magnitude of the leak is 0.016 
mmol. Li‘*'(ml cells)"^h-^ (29). This mechanism is inhibited partly by phloretin and is 
also inhibited by dipyridamole which, interestingly, inhibits the uptake of Na"** and K+ 
by leak pathways in rat erythrocytes to a similar extent, suggesting the pathways may 
have the same mechanism (30).
The passive transport of Li'*' is enhanced in the presence of the bicarbonate 
anion, HCOg" (31), and this effect is approximately four times greater than that of the 
similar transport of Na'*' (32). In this process, Li*** forms an ion pair with the carbonate 
ion COg^", which is in equilibrium with HCO3" in solution and the resulting single- 
negatively charged species, (LiiCOg)", provides a substrate which can then cross the 
erythrocyte membrane by the anion exchange mechanism; the transporter for this 
pathway is part of the band 3 protein which spans the erythrocyte membrane (33). This 
countertransporter mediates the movement of monovalent anions such as halides, 
HCO3", NO3", phosphate and sulphate, in a one for one exchange. The mechanism 
for Li'*' transport was characterized by its inhibition by compounds known to inhibit the 
anion exchange system in erythrocytes for example: dipyridamole, SITS, phloretin, 
phlorizin, phenylbutazone, ethacrynic acid and furosemide (29,30). The rate of 
transport is linearly dependent on both the extracellular [Li+] and the [HCO3"] and is 
very similar to that of the leak, being 0.019 mmol. Li'**(ml cells)" ^ h"! for a ImM 
difference in [Li'*'] and an extracellular [HCO3"] of 24mM (29).
The Li"*'-Na'*' countertransport is an active pathway which can transport Li'*' in 
either direction depending on the distribution of Li'*' and Na'*' on the two sides of the 
membrane (34,35). The stoichiometry of the process is one to one and can involve 
homo-, or heteronuclear exchange; for every Li'*' and/or Na”*" transported in one 
direction, one Na'*' and/or Li'*' is transported in the opposite direction across the 
membrane. The movement of Li'*' is dependent upon the presence of either Na'*' or Li’*'
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on the trans side, and is inhibited by Na+ on the cis side of the membrane such that 
Li"*" can be transported into the erythrocyte only in the presence of intracellular Na+ or 
Li'*', and vice versa. The mechanism for this transport is believed to be the same as the 
Na'*'-Na+ exchange system found in erythrocytes, as the two share many 
characteristics: both involve one for one exchange of the cation (36), both are 
insensitive to ouabain (34,35) and are inhibited by phloretin, phlorobenzophenone and 
N-ethylmaleimide (36); both observe Michaelis-Menten kinetics (36,37); and the 
transport rates of the two processes are similar. The system has a much higher affinity 
for Li+ than Na'*' and, apparently, no affinity for any other cations (35). The respective 
values of for Li"** and Na"*' are 0.5mM and 9.0mM at the internal, and 1.5mM and 
25.0mM at the external side of the erythrocyte membrane (37), where is the 
concentration of cation required to give half-maximum activation of the transport 
system. Thus the affinities of this transport system for both cations is approximately 
three times greater at the internal than the external side of the erythrocyte membrane.
Under physiological conditions this process transports Li'*' out of erythrocytes 
against its concentration gradient and is thus responsible for maintaining the 
intracellular [Li'*'] lower than that in the plasma in vivo. The driving force is the Na"*" 
gradient across the erythrocyte membrane ([Na'*'] extracellular is approximately 150mM 
and intracellular is approximately 5-lOmM); this process is not directly dependent on 
ATP (35).
The Na'*'/K'*' pump is the most ubiquitous ion transport system in animal cells, 
creating and maintaining the Na"*" and K"*' gradients across membranes and also 
maintaining the osmotic equilibrium. The driving force for the pump is the energy 
produced during the hydrolysis of ATP by the enzyme Na'*'/K'*'-ATPase, a protein 
which spans the membranes of cells. For each molecule of ATP hydrolysed to ADP 
and Pi, 2K'*' are transported into, and 3Na'*' are transported out of the cell. Ouabain, a 
cardiac glycoside, is a potent inhibitor of Na'*'/K'*'-ATPase, competing with K'*' at the 
external pump sites: the pump is also inhibited by oligomycin and ethacrynic acid (28).
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Li"*" can be transported by this route either into, or out of, erythrocytes only in the 
absence of extracellular K"*", or intracellular Na+ respectively. Extracellular K+ and, to 
a lesser extent Na"*", inhibit Li+ uptake in a competitive manner, and intracellular Na**" 
and/or K+ completely inhibit the transport of Li+ by this route (28,38). The external 
site of the Na"*"/K+ pump has a lower affinity for Li+ than K+ and the internal site has a 
much lower affinity for Li+ than Na"**. Under physiological conditions of [K+] and 
[Na+] and at the low [Li+] found in blood plasma in vivo during therapy, the 
movement of Li'*’ through the erythrocyte membrane mediated by the Na+ZK'*' pump is 
negligible
In the Na"*'-K'*' cotransport system, INa"**, IK"*" and 2C1" are transported 
together in the same direction across the cell membrane, and the direction of movement 
can be in either direction (39). This process is blocked by ‘loop’ diuretics such as 
furosemide, bumetanide and piretanide, and is insensitive to ouabain. The movement 
of Li"*" can also be mediated by this cotransport by replacing the Na"*" (37,40).
1 .5 .4  Variability in Li'*'Transport
The ratio, Li+in /Li+out» human erythrocytes ranges from 0.2-0.9, illustrating 
a large interindividual variability (41). However, this ratio is relatively constant over 
long periods of time for individuals and there is evidence that this phenomena is under 
genetic control (42). During the first days of Li+-treatment, the ratio increases 
gradually until a steady-state value is attained (25). Higher ratios have been reported in 
patients with affective illnesses compared to healthy subjects (43,44) and in females 
compared to males (45). There have been attempts to correlate the higher Li+ ratio to a 
better clinical response of patients to Li"*" therapy (46,47).
Since the steady-state Li+ ratio depends upon the balance between the efflux 
and influx processes, the countertransport system, and the leak and the anion exchange
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routes respectively, a number of groups have investigated these variations in Li+ ratio 
by looking for differences in the Li+ transport processes. These studies were 
performed with erythrocytes from both normal controls and psychiatric patients. 
Neither of the passive transport routes, the leak and the bicarbonate pathway appear to 
vary amongst healthy controls (36). However, significant variability amongst 
individuals was found in in vitro studies of the transport of Li+ by the Na -^Li"*" 
countertransport mechanism (36,37). Hence the variation in the steady state Li+ ratios 
is believed to be due primarily to differences in the Na -^Li"*" countertransport 
mechanism; a higher Li+ ratio arising almost exclusively from a lower activity of this 
mechanism (36,48). Significant individual variation in the maximal transport activity, 
Vmax» has been reported by a number of groups (36,38). Sarkadi (37) reported a 
range of 0.1- 0.37 mmol.Li+(l cells)"lh“l. Interestingly, this transport process appears 
to show little variability over time within an individual (36,49), indicating that the 
magnitude of this transport process is a characteristic property of the erythrocyte 
membranes of an individual and thus suggesting the involvement of a genetic 
component (42).
Differences in the Na+-Li+ countertransport process have also been observed in 
the erythrocytes of psychiatric patients (50,51,52). Pandey reported that this process 
was generally slower in bipolar patients than in normal controls, leading to higher Li+ 
ratios (51). There was a great deal of variability amongst the patients and many had 
Li+ ratios in the ‘normal’ range.
A decrease in the efficiency of the Na^ -Li"*" countertransport also appears to be 
a direct result of Li+ administration (44,49); a 50% inhibition in efflux of Li+ from the 
erythrocytes of people on Li+ therapy has been reported (44). This reduction in the 
transport rate is not an immediate effect of commencing Li+ treatment; the decrease in 
activity has been observed 2-4 days after commencing therapy and the maximum 
reduction appears within 7 days. The rate of transport returns to normal soon after the 
Li+ therapy is ceased (53).
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This Li‘*‘-induced reduction in the transport rate appears to be distinct from the 
interindividual variation, as the two show different kinetics (49): In the Li+-induced 
change, K^j increases threefold but V^ax does not change, whereas in the 
interindividual case, it is V^ax which varies (53). Ehrlich suggests that the protein 
responsible for this transport mechanism may be modified in a way which involves no 
change in the number of these proteins available for transport per cell, thus explaining 
the lack of effect on the Vmax
One interesting study reported that the in vitro exposure of erythrocytes to Li+ 
caused an inhibition of the Na^ -Li"*" countertransport mechanism similar to that seen in 
vivo (54). It was proposed that Li"*" might alter the lipid composition of the erythrocyte 
membrane, for example by altering the rate of choline production from phospholipid, or 
that Li"*" might alter the transport process of some other solute, the resulting altered 
concentration of which might affect the countertransport mechanism.
Variations in the Na+-Li+ transport mechanism in other mammalian species 
namely: sheep, beef, horses and rabbits have also been observed (55). Here, as in the 
cases of the interindividual differences, the maximal transport activity, Vmax» is 
altered, being lowest in humans and significantly higher in the others. Interestingly, 
there was no corresponding Na^ -Li*** countertransport process found in rat erythrocytes
(55); Li+ transport via the ’leak' route is approximately 3-fold greater in rat erythrocytes 
than in humans (30).
1 .5 .5  LÎ+ Transport in Other Cells
Erythrocytes share transport mechanisms with many other cells although 
surprisingly the Li+ transport pathways in other cell types has received little attention 
and the available data is not very informative. Most work shows that, as in the case of 
erythrocytes, the intracellular [Li+] is lower than the extracellular and is below that
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expected for passive diffusion of the cation across the cell membrane, although there 
some reports which contradict this. The transport mechanisms are not well understood 
in any of these systems and have not been fully characterised. As with erythrocytes, 
the composition of the incubating medium, particularly with respect to [Na+] and [K+], 
can significantly affect the transport behaviour of Li+. The Na /^K"** pump can 
transport Li"*" in most cell systems but it is considerably inhibited in physiological media 
just as in erythrocytes. Many tissues, including brain and muscle exhibit a similar 
Na+-Na+ exchange system to that observed in human erythrocytes (29), however the 
majority of cells lack the anion transporter present in erythrocytes. The intestinal 
absorption of Li+ following oral administration occurs primarily in the small intestine
(56). Transport into the bloodstream is a passive process via a paracellular route, with 
very little Li+ accumulating in the intestinal cells (56,57,58). One significant feature of 
excitable cells, such as nerves, is the presence of the voltage-dependent Na+ channel 
which is not found in erythrocytes and in non-excitable cells in general. The 
permeability of this transporter to Li+ is almost the same as that to Na+ (Table 1.3) 
and, as with Na"**, the cell membrane may become dramatically more permeable to Li+ 
in the excited state. Veratridine, an alkaloid which activates these Na+-channels, 
significantly increases the initial rate and the extent of Li+ uptake in mouse 
neuroblastoma cells (59) and in mouse neuroblastoma x glioma hybrid cells (60).
Table 1.3 Relative permeabilities of the Na'**-channel and the K+-channel in axon
membranes (61)
Cation Na+-channel K+-channel
Li+ 0.93 <0.01
Na+ 1.00 <0.01
K+ 0.09 1.00
Rb+ <0.01 0.91
Cs+ <0.01 <0.08
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The reported studies on cultured cells emphasise the variability in the 
intracellular Li+ concentrations which might be expected if these result from the 
integration of several transport pathways in each cell type. Expressed as a ratio of 
Li+in/ Li+out» values of 5.6, 1.5, 0.3 and 0.7 have been reported for rat glioma cells 
{62), mouse neuroblastoma cells {59), mouse neuroblastoma x glioma cells (60,63) and 
primary chick embryo brain containing mixed populations of neuronal and glial cells 
(64,65), respectively. In general, these cells have faster transport rates than those 
observed for erythrocytes since the intracellular Li+ achieves steady-state within 20-60 
minutes, compared to several hours for erythrocytes. The involvement of voltage- 
dependent Na+-channels and a Na+/Li+ countertransport mechanism, similar to that 
operating in erythrocytes, has been reported for neuroblastoma x glioma cells, and the 
Na+/K+ pump appears to have a role in Li+ transport in a human neuroblastoma cell 
line (66).
1 .6  Nmr of Alkali Metals in Biological Systems
The chemical shift of all of the alkali metal ions in aqueous systems, except 
Cs+, is virtually independent of the environment of the cation. Therefore, in biological 
systems where the cations can be distributed among several environments, for example 
intra-, and extracellular, in perfusate or in tissue, the nmr spectrum of a particular cation 
generally only contains a single peak corresponding to the overlapping signals from 
each environment. The resonance from a cation in a specific environment can be 
distinguished from those of the cation in other regions by the addition of a 'contrast' 
reagent to that environment.
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1 .6 .1  Contrast Reagents
There are two types of contrast reagent: shift reagents, which produce a 
chemical shift of the resonance from the cation in the same environment; and relaxation 
reagents which result in a significant increase in the line-width of the resonance from 
the cation in the same environment until the signal is no longer visible. The use of 
contrast reagents in the nmr spectroscopy of the alkali metal ions in biological systems 
results in the resolution of signals from cations in distinct environments, thus allowing 
the behaviour of the cations in these pools to be investigated independently and the 
transport of the cations to be studied by this non-invasive methodology. In order to be 
effective in these studies, the contrast reagent must be stable and soluble in 
physiological conditions, it must be non-toxic to the cells or organisms, it must not 
penetrate or interact with the cell membrane, and it must not bind strongly with the 
cation to the extent that the transport behaviour and trans-membrane gradient of the 
cation are disturbed.
In this study, a paramagnetic shift reagent has been employed to distinguish the 
intra-, and extracellular Li+ resonances in the nmr spectra.
1 .6 .2  Shift Reagents
A number of anionic complexes of the paramagnetic lanthanides, Dy^+ and 
Tb^ "*", have been investigated as potential chemical shift reagents for the alkali metal 
cations, as these lanthanides have been shown to produce relatively large shifts (67). 
In general, larger shifts are obtained using complexes with highly negative charges; the 
structures of those discussed here are shown in Figure 1.2.
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Figure 1.2 Structure of ligands of the lanthanide shift reagents
1 AD?3", adenosine diphosphate; 
3 PsOio^", tripolyphosphate;
5 CA^“, chelidamate, 
4-oxypyridine-2,6-dicarboxylate;
7 NTA^", nitrilotriacetate;
2 P2 O7 4 -, pyrophosphate;
4 P40i3^’, tetrapolyphosphate;
6 DPA^‘, dipicolinate, 
pyridine-2,6-dicarboxylate;
8 EDTA^-, ethylenediaminetetraacetate;
9 TIHA^-) triethylenetetraminehexaacetate)
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Both of the higher negatively-charged complexes, Dy(NTA)2^" and 
Dy(DPA)3^", produce larger upfield shifts of the ^^Na resonances than the single- 
negatively charged complex, Dy(EDTA)“ (68), Dy(CA)3^" produces significant 
upfield shifts of the ^^Na, and ^^Mg resonances, whereas Tm(CA)3^-
produces a downfield shift of the ^^Na resonance (69), In an investigation of various 
polyphosphate ligands with Dy3+, the highly negatively-charged 1:2 complex between 
Dy3+ and tripolyphosphate, Dy(P3O l0)2 "^» was found to be an extremely effective 
shift reagent for 23Na, producing larger shifts than the Dy^+ complexes of either ADP, 
pyrophosphate or tetrapolyphosphate (70), Although the shifts produced by 
Dy(P30io)2^" and Tm(P30io)2^~ are the largest, they are strongly pH-dependent and 
are significantly decreased by the presence of either Ca^+ or Mg2+, which compete 
both with the monovalent cation for the shift reagent, and with the lanthanide ion for the 
ligand (71,72). In comparison, the complexes Dy(TTHA)3- and Tm(TTHA)3- are also 
effective as shift reagents albeit to a lesser extent than the complexes of P3 0 io^"î the 
shifts produced are downfield but are much less sensitive to pH and to the presence of 
divalent cations (71,72),
1 .6 .3  Shift Reagents for the Alkali Metals in Biological Systems
In the first reported biological application of the use of these reagents, the 
^^Na- nmr spectra of samples of gently packed erythrocytes showed two well-resolved 
resonances when maintained in a medium containing 140mM Na" ,^ lOmM K+ and 
concentrations of Dy(P30io)2^' of 2mM and 5mM (70), The magnitude of the upfield 
shift of the resonance from the extracellular Na+, (Na'^out)» increased with increasing 
concentration of the shift reagent, and only a small amount of line-broadening was 
induced by the shift reagent. The resonance from the intracellular Na+, (Na+i^), was 
unshifted from the resonance of Na+ in the spectrum of the cell-free medium containing 
no shift reagent, indicating that the Dy(P3 0 io)2^ ' had not penetrated the cell
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membrane. The application of this shift reagent in the study of Na+ in different 
environments in frog skeletal muscle was also demonstrated (70). Similarly, 
Dy(P3 0 10)2^“ was employed to shift the resonance from samples of
human erythrocytes (73), however Tb(P30io)2^“ was shown to be a more effective 
shift reagent for K+ producing a slightly larger chemical shift with a correspondingly 
smaller induced line-broadening (74).
23Na-nmr studies were carried out on samples of human erythrocytes using 
D y(P30io)2^' and Tm(TTHA)3- which shifted the resonance from the Na+out 
upfield, and also Dy(TTHA)3- and Tm(P30io)2^" which shifted this resonance 
downfield (75). The Tm3+ complexes producing substantially lower shifts than the 
corresponding Dy3+ complexes. Quantification of both the intra-, and the extracellular 
[Na+] was achieved by the construction of a calibration curve from the integrals of the 
Na+ resonances in the spectra of NaCl standards. The results were within ± 5% of the 
values determined by flame emission spectrophotometry indicating the absence of nmr 
invisibility for Na"*" in this system.
Similarly, Dy(P30io)2^" and Dy(TTHA)3- were investigated as potential shift 
reagents for Li+ in erythrocyte suspensions and, as expected from the results on Na+, 
Dy(P3 0 io)2^ ' produced the larger separation of the two resonances, but the shifts 
produced by Dy(TTHA)3- were virtually independent of pH and were less dependent 
upon [Ca^+] and [Mg2+] (76). The use of these shift reagents in ^Li-nmr 
spectroscopy is described in more detail in Chapter 3 of this thesis.
No adverse effect on either the energy metabolism or the morphology of 
erythrocytes was observed due to either of the shift reagents Dy(P3 0 io )2 ^“ and 
Dy(TTHA)3-, following investigation by 31p-nmr and by scanning electron 
microscopy (SEM) (76,77). The shape and size of the erythrocytes remained virtually 
unchanged in the presence of the relatively low concentrations of Dy(P3 0 io)2 "^» 
Dy(TTHA)3", Tm(P3Oi0)2^" and Dy(P02(CH2P03)2)^“ typically used in the nmr
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experiments. However, as the concentrations increased above about lOmM an 
increasing amount of shrinkage occurred in the cells (77). Additionally with the 
exception of Dy(TTHA)3-, these shift reagents produced significant changes in the 
membrane potential of the erythrocytes, and therefore it was suggested that these agents 
should be employed with caution (77).
1 .6 .4  Structure of Dy(P3Ol0)2^"
In this thesis, Dy(P30io)2^~ has been employed to distinguish between the 
intra-, and extracellular Li+ resonances in suspensions of erythrocytes and cultured 
cells. The proposed structure of the 1:2 complex between Dy3+ and P30 io^“ is 
shown in Figure 1.3 with a coordination number of 9 for the metal centre (78). 
P3O i0^“ acts as a tetradentate ligand in which one of the PO3 groups is bidentately 
coordinated, the other PO3 group and the PO2 group are monodentately coordinated, 
and one molecule of H2O is coordinated in the first coordination sphere (79). The 
interconversion of the coordination of the two PO3 groups is rapid. This model 
predicts that there are no specific binding sites for the alkali metal cations, but that up to 
seven cations can bind in the second coordination sphere to neutralise the negative 
charge. At pH 7.5 several protonated forms of the complex exist: Dy(P30io)2^"> 
Dy(P3O l0)(P3O9OH)6- and Dy(P3090H)2^‘ (80). As the pH is lowered an 
increasing amount of protonation occurs and as the negative charge on the complex 
decreases, the interaction with the cation is weaker and the resulting chemical shift of 
the cation in the nmr spectrum is reduced (72). The shifts produced by Dy(P30io)2^“ 
in the nmr spectra are also reduced by the presence of other cations which compete for 
the shift reagent and the relative order of competition is: Ca^+ > Mg^+ > Li+ > Na+ > 
K+. All these cations compete for the binding sites in the second coordination sphere 
in a reaction of the type:
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xNa’*’:Dy(P30io)2^ " + i r  yNa+M"'^;Dy(P30,o)2'' + nNa7-
where, M "+= Li+, Na+, K+, M g2+, Ca2+; l S x S 7 ;  n=l,2
whereas the divalent cations also compete with the Dy3+ for the ligand in a reaction of 
the type:
D y(P3 0 io)2’ - + M2+ M(P30,o)*- + Dy(P30io)^-
where, = Ca^ "^  or
Oo Dy3+
FIGURE 1,3 Structure of Dy(P3 0 10)2"^ "
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Chapter 2
Experimental
35 i
2 .1 .1  Human Erythrocytes for Li+ Uptake Studies
Venous blood (usually 20ml) was drawn from healthy volunteers from within 
the Chemistry Department, University of St. Andrews, by qualified staff at either the 
Occupational Health Department or at the Health Centre in St. Andrews. Blood from 
patients was obtained from either the psychiatric clinic at the Ninewells Hospital, 
Dundee or from the Royal Liff Hospital, Dundee. The blood was immediately 
transferred into tubes containing either sodium heparin or citrate-based anticoagulant 
(7mM citric acid, 93mM trisodium citrate, 139mM dextrose). In the latter, the ratio of 
blood:anticoagulant was 1:9. The blood was centrifuged for approximately 5min. and 
the plasma was removed by aspiration. The erythrocytes were then washed with the 
intended incubation medium, centrifuged and the supernatant aspirated. This procedure 
was repeated at least three times before the isolated erythrocytes were resuspended in 
the incubating medium.
2 .1 .2  Rat and Rabbit Erythrocytes for Li+ Uptake Studies
All animal handling was performed by A.N. Carter of the University of 
Dundee. Immediately after killing the rats using CO2, whole blood was obtained by 
cardiac puncture from 3 female rats and pooled together (approximately 16ml), and by 
venepuncture of the inferior vena cava of 1 rat (approximately 15ml), and transferred 
into tubes containing citrate anticoagulant (3ml). Whole blood (20ml) was obtained by 
venepuncture of the peripheral ear vein of the live rabbit and transferred immediately 
into a tube containing sodium heparin. The erythrocytes were then isolated as above.
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2 .1 .3  Li+Uptake Into Erythrocytes
The fresh erythrocytes were incubated overnight as a dilute suspension 
(approximately 4% haematocrit) at room temperature in an isotonic medium (Buffer A: 
40.0mM NaCl, 16.8mM KCl, 2.0mM CaCl2, 1.2mM MgCl2, 4.75mM NagPO^, 
lOmM dextrose, 15mM NagPgOig, 0.5mM DyClg, pH 7.4). This removed most, but 
not all, of the intracellular Li+ found in the erythrocytes of the people taking lithium 
salts. At the start of an experiment the incubating medium was changed to Buffer B 
(Buffer A + 2mM LiCl) by centrifuging and washing the erythrocytes three times in 
Buffer B before resuspending the erythrocytes at approximately 8% haematocrit. The 
suspension was incubated at 37°C in a thermostatted water bath and was intermittently 
agitated gently to prevent the erythrocytes settling. Zero time for the experiment was 
taken as the time when the erythrocytes were first exposed to Buffer B. For each nmr 
measurement an aliquot of gently packed erythrocytes (2ml) was obtained by 
centrifuging a pre-determined volume of the suspension for 2min.; the supernatant was 
aspirated and discarded, and the erythrocytes were transferred to a 10mm nmr tube 
which was then fitted with a 4mm outside-diameter (o.d), coaxial insert containing 
2H2O. The haematocrit of the sample was typically 85%. The time point recorded for 
each spectrum was the midpoint of the data acquisition period. After recording the 
spectrum the erythrocytes were returned to the stock suspension and simultaneously 
fresh buffer was added (the same volume as that previously discarded) to maintain both 
the Li+ concentration and the haematocrit of the suspension.
2 .1 .4  Nmr Spectroscopy of Erythrocytes
All the nmr spectra were recorded using the high-resolution probes on either a 
Bruker AM300 or a Bruker MSL500 Fourier-transform spectrometer at the frequencies 
shown in Table 2.1. Spectra recorded on the MSL500 spectrometer had at least twice 
the signal-to-noise ratio than those from the AM300 spectrometer. Each spectrum was
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field/frequency locked on the %  resonance of contained in a 4mm-o.d. insert 
tube placed coaxially in the 10mm sample tube. Free induction decays (FID's) were 
acquired in a data block just sufficiently large to contain all the visible decay. After 
applying an appropriate line-broadening factor to improve the signal-to-noise ratio the 
FID's were subsequently transformed in a larger data block to improve the digital 
resolution in a process known as 'zero-filling' (1).
Table 2.1 The respective nuclear frequencies on the Bruker AM300 and Bruker
Nucleus AM300 MSL500
7li 116.638 194.366
23Na 79.388 132.294
39K 14.006 23.336
133Cs 39.367 65.597
31p 121.513 202.458
For all quantitative work, spectra were recorded and transformed under identical 
conditions. 90“ pulse widths were determined, by first obtaining the 180“ pulse width 
by adjustment of the pulse length until no signal is produced, and then dividing the 
pulse length by 2 f2). That the resulting pulse length generated the maximum signal 
intensity was double checked. T% values were determined by the standard inversion- 
recovery method (3), 90“ pulses were applied with a repetition rate of greater than 5 
times the relaxation time of the slowest relaxing nuclei, thus allowing sufficient time for 
all the nuclei to be completely relaxed before applying the next pulse. The Li+ 
resonances of both suspensions of erythrocytes and aqueous solutions, containing
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known concentrations of LiCl over the concentration range 0.05-1.00mM, were 
compared directly. For a given [Li+], there was no significant difference between the 
integral of the Li+ resonance in the erythrocyte sample and the aqueous solution, 
confirming the validity of the quantitative method employed in this work.
2 .1 .5  7lî Nmr Spectroscopy of Erythrocytes
Typically 100 FID's were collected into IK data points with a sweep width of 
lOOOHz (1.95Hz/pt). The repetition rate between pulses was generally 30s and 
therefore the total acquisition time for a spectrum was 50min. The FID's were zero- 
filled to 8K data points (0.24Hz/pt) and transformed with a line-broadening factor of 
typically 4Hz. A typical spectrum is shown in Figure 2.1(A). Assignment of the 
resonance from the extracellular Li+ was achieved by comparison of the spectra of the 
erythrocyte samples with a spectrum of a reference sample of the incubating medium 
Figure 2.1(B), the two resonances having the same chemical shift. Therefore, the 
second resonance in the spectra of the erythrocyte samples was from the intracellular 
Li+, being unaffected by the extracellular shift reagent. This second resonance occurs 
at the same chemical shift as that arising from Li+ in aqueous solutions of LiCl in the 
absence of shift reagents. In all spectra the chemical shift of the extracellular Li+ 
resonances was referenced to the intracellular Li+ resonance which was consistently set 
at Oppm. The line widths at half height, COj/2» are lOHz and 16Hz for the intracellular 
and extracellular signals respectively and the separation between the peaks is 0.64ppm.
Quantification of the intracellular Li+ levels in each sample of packed 
erythrocytes was achieved by comparing the ^Li spectrum of the sample (2ml) with a 
reference spectrum of the incubating medium (2ml) containing 2mM Li+, which was 
recorded and transformed under identical conditions. The spectrum of the incubating 
medium. Figure 2.1(B), was integrated and the area under the peak set at 100 for 
convenience (i.e. 100% of the sample was occupied by the incubating medium at 2mM
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[Li+]in = 0.095mM [Li+]out = 2.00mM
A
B
- 2 . 0 0- 1.001 .002 . 0 0 PPM
Figure 2.1 ^Li nmr spectra of (A) a sample of erythrocytes after 428min. 
incubation in Buffer B (2mMLi+) at 37“C, and (B) Buffer B 
(Each spectrum is the sum of 100 acquisitions recorded at 194MHz on the MSL500
nmr spectrometer)
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Li+). Each sample spectrum was then transformed with the same absolute intensity. 
The percentage volume occupied by the extracellular medium was given by the integral 
of the signal from the extracellular Li+, since the concentration was the same as 
that of the reference sample (2mM), Therefore the remaining volume in the sample was 
that occupied by the erythrocytes (i.e. the haematocrit ) and was thus given by:
Haematocrit (%) = 100-lom
The intracellular Li+ resonance corresponding to this haematocrit was integrated, 1^ ,^ 
and the intracellular [Li+] was thus given by:
[Li+]i„ = lin X X
Substituting for [Li+]j^f = 2mM, and = 100, then the intracellular Li+ concentration 
in all the samples of packed erythrocytes could be calculated from the integrals of the 
two resonances by:
2 .1 .6  3lp Nmr Spectroscopy of Erythrocytes
A sample of fresh blood in the citrate-based anticoagulant was centrifuged 
approximately 2h after it had been drawn. The buffy coat and white cells were 
removed by aspiration and an aliquot of the gently packed erythrocytes (2ml) was 
transferred to a 10mm nmr tube, which was then fitted with a 4mm-o.d. coaxial insert 
containing 2H2O. The 3Ip nmr spectrum of the sample was then recorded. The 
remaining erythrocytes were collected, isolated and incubated as in the Li+ uptake 
experiments. spectra of samples of gently packed erythrocytes were recorded at 
time intervals throughout the incubation period. Typically 240 FID’s were acquired 
with a repetition rate of 2s, in a 2K data block with a sweep width of lO^Hz
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(9.77Hz/pt), and transformed in an 8K data block (2.44Hz/pt) with 15Hz line- 
broadening. All spectra were referenced to the resonance of a solution of H3PO4 
(10% w/v) set at Oppm.
2 .1 .7  Erythrocyte Viability
The viability of the erythrocytes throughout the lifetime of the experiments was 
demonstrated in a number of ways: by the absence of haemolysis, which was indicated 
by the non-appearance of the red colour of haemoglobin in the supernatant; by periodic 
monitoring of the morphology of the erythrocytes by microscopic examination, to 
ensure that the normal biconcave shape was maintained; and by the use of 31p nmr 
spectroscopy. Haemolysis was usually accompanied by a significant increase in the 
apparent intracellular [Li+].
3lp nmr spectroscopy is a potent method to investigate the intracellular 
environment, particularly intracellular pH. Figure 2.2A shows the ^^P nmr spectrum 
of a sample of packed erythrocytes which was recorded just 2h after the blood had been 
drawn and prior to the incubation procedure. This was compared to the 3lp nmr 
spectra of erythrocyte samples after 0.5 and 24h incubation in Buffer B at 37“C, Figure 
2.2B and Figure 2.2C respectively. The signals at 3.10 and 2.14ppm are assigned to 
the 3- and 2-phosphate groups of 2,3-diphosphoglycerate (2,3-DPG), and the signals 
at -5.54, -10.55, and -19.27ppm are assigned to the y, a  and p phosphate groups of 
ATP (4). The two additional peaks in Figure 2.2B and 2.2C, at -7.09 and -20.87ppm, 
are assigned to the a  and p resonances from PgOio^- in the extracellular medium.
The consistencies of the intensities and the chemical shifts of the resonances 
from both ATP and 2,3-DPG confirm that the levels of phosphorous metabolites in the 
erythrocytes are unchanged, even after 24h incubation, and also that the intracellular pH 
is constant. The chemical shift difference between the y, and a  resonances of ATP
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B5 - 5 -100 -15 - 2 5-20PPM
Figure 2.2 31p nmr spectra of human erythrocytes in (A) blood plasma, 2h after 
collection, (B) Buffer B, after 0.5h incubation at 37°C, and (C) Buffer B, after 24h
incubation at 37°C
(1,2 2,3-DPG, ay-ATP, 4 a-PgOio^", 5 a-ATP, 6 p-ATP, 7 p PsOio^-)
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(Ôay) is a good indicator of intracellular pH (4), Thus, the viability of the erythrocytes 
throughout the lifetime of the experiments was confirmed.
A particular problem with erythrocyte viability was experienced at one stage 
during this work. A slight haemolysis during the initial washing procedure, followed 
by a gradually increasing amount of lysis during the incubation period of the uptake 
experiment was observed for a number of such experiments. This was accompanied by 
much higher intracellular [Li+] being attained than in previous experiments. 
Microscopic examination showed the erythrocytes with a considerably altered shape 
with an abundance of irregularities on the normally smooth exterior surface (crenation). 
The problem was investigated and was eventually identified as an adverse osmotic 
effect due to a new batch of NagPgO^o, which was used in the incubating medium. 
This had been acquired from Aldrich as opposed to that previously used from BDH. 
The BDH material contained a higher amount (approximately 18%) of than the 
Aldrich material (approximately 6%) and also contained a small amount of PgOg^" 
(approximately 0.1%), as determined by ^^P nmr spectroscopy of the aqueous 
solutions. The ionic composition of the incubating medium was originally designed 
using Na^PgO^o fi*om BDH. The consequence of using the Aldrich salt when preparing 
the buffer was a significant difference in the ionic strength , i.e.the buffer was no 
longer isotonic and resulted in lysis of the erythrocytes. All experiments using this 
material were therefore repeated using the BDH salt.
2 .1 .8  Effect of Overnight Incubation Upon the Uptake of Li+
The effect of the overnight incubation procedure required for the erythrocytes 
already containing Li+, on the uptake of Li+ into erythrocytes was investigated. The 
isolated erythrocytes from a blood sample from one healthy individual were divided 
equally; a Li+ uptake experiment was carried out immediately using one half of the 
erythrocytes and the remaining erythrocytes were incubated in Li+-free buffer for 23h
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before the uptake experiment was performed. The results are illustrated in Figure 2.3 
and, although there was no significant effect caused by the incubation procedure, as 
illustrated by the similarity in the two profiles, it was decided to follow identical 
procedures for all the Li+ uptake experiments so that valid comparisons could be made. 
Therefore, the erythrocytes from both patients and controls were incubated overnight, 
in a Li+-free medium, prior to the experiment.
[Lili^/mM
0.20-1
0.15-
Preincubationtime/h0.10-
0.05-
0.00 + 
0 500Incubation Period /min.1000 1500
Figure 2.3 A comparison of the uptake of Li+ into fresh erythrocytes and into 
erythrocytes incubated for 23h in a Li+-free medium
2.2 Human 1321 N1 Astrocytomas
This is a cell line originally derived from a human brain tumour in the early 
1970*s. The cells were cultured on the surface of microcarrier beads (Nunc Biosilon, 
diameter 250pm), by A.N.Carter of the University of Dundee. These beads allow very 
high density cultures to be obtained, having a surface area in the range 250-300cm^ per 
gram of beads, thus allowing a maximum density of approximately 10  ^cells g"  ^beads 
to be obtained.
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The cells were cultured in Dulbecco's-modified Eagles medium containing 
foetal calf serum (10% v/v), Gentamicin - a broad spectrum antibiotic (5pg ml'^) and 
Amphotericin B - an anti-fungal agent (2.5pg ml-l). The cells (2 x 107) were seeded 
onto the microcarrier beads (5g) in a 75cm^ culture flask containing culture medium 
(25ml). The flask was then transferred to a humidified incubator in an atmosphere of 
5% CO2, 95% air and left for 2 days with periodic gentle mixing. After this time the 
beads were allowed to settle and the medium aspirated. The beads were transferred to a 
175cm^ flask, fresh medium added (100ml), and they were then replaced in the 
incubator for 2 days with periodic mixing. The medium was replaced in this way every 
2 days for a further 10 days, after which time the beads, now carrying the cells, were 
used for an experiment. For one particular experiment, LiCl (16.7mM) was included in 
the culture medium in the 24h preceding the nmr experiment in order to obtain a 
significant intracellular [Li+].
2 .2 .1  Nmr Studies of Astrocytomas
Prior to an nmr experiment, Hepes (20mM, pH 7.2) was included in the culture 
medium and the suspensions were maintained at 37°C in a thermostatted water bath. 
For each nmr experiment, an aliquot of the suspension was transferred to a 10mm nmr 
tube, the beads were allowed to settle under gravity and the supernatant was aspirated. 
This process was repeated until a sufficient volume of beads was obtained. By 
repeated washings and aspirations, the extracellular medium was changed to Buffer C 
(lOmM Hepes, lOmM LiCl, 80mM NaCl, lOmM NagPgOio, 3mM DyClg, 2.7mM 
KCl, 0.5mM MgCl2, 1.4mM CaCl2, 0.04mM NaH2P04, 30mM dextrose, adjusted to 
pH 7.2 with Tris base). This buffer was adapted from that employed in the 23Na-nmr 
study of rat mucosal mast cells (5). For the experiment at the higher [Li+] of 50mM, 
LiCl was substituted for NaCl in the buffer.
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All spectra were recorded on the MSL 500 spectrometer. The spectrometer was 
field/frequency locked, and the magnet was shimmed using a sample tube containing a 
fixed volume of the microcarrier beads in a fixed volume of aqueous solution 
containing D^O (20%v/v), LiCl and NaCl. Thereafter, no further shimming was 
performed and the spectra were recorded unlocked with all samples containing the same 
volumes of beads and solution as the above sample.
For the ^^Na spectra, typically 1200 FID’s were collected into IK data points 
with a sweep width of lO^Hz (19.53Hz/pt) and a repetition rate of 0.2s, thus giving an 
acquisition time of 4min. The FIDs were zero-filled to 8K data points (2.44H?/pt) and 
transformed with a line-broadening factor of typically 20Hz. ^Li spectra were collected 
into 2K data points with a sweep width of 8000Hz (7.88Hz/pt) and a repetition rate of 
30s. The FID’s were zero-filled to 8K data points (1.97Hz/pt) and transformed with a 
line-broadening factor of typically 20Hz. Reference spectra for both Na+ and Li+ were 
obtained on samples of the buffers alone and on samples of the buffers containing 
beads without cells. 31p spectra were collected into 2K data points with a sweep width 
of 15000Hz (14.80Hz/pt) and a repetition rate of 2s. The FID's were zero-filled to 8K 
data points (3.70Hz/pt) and transformed with a line-broadening factor of typically 
20Hz. The chemical shifts were referenced to the resonance in an aqueous solution 
of H3PO4 (10% w/v).
2 .2 .2  Cell Viability
31p nmr spectra were recorded on the suspensions in both the culture medium 
and in Buffer C to ensure the viability of the cells. Not having the necessary equipment 
for perfusing the cell suspensions in the spectrometer it was found that, by ensuring 
sufficient buffer was present to almost completely fill the nmr tube, the suspension 
could be periodically mixed by gentle inversion of the tube, thus ensuring that the cells 
were not depleted of oxygen or other necessary nutrients. If left without this mixing
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procedure for long periods of time, the shape of extracellular resonance, in both the 
23Na and ^Li-nmr spectra, altered significantly. A broad shoulder appeared on the 
upfield side of the extracellular signal which is probably due to the action of a 
pyrophosphatase, associated with the cells. This enzyme will catalyse the 
decomposition of the PsOio^” to orthophosphate, thus reducing the concentration of 
shift reagent in the immediate extracellular environment of the cation. The activity of 
such an enzyme with this shift reagent has been observed in a number of other 
mammalian tissues (6), Interestingly, by mixing the cell suspension by inversion of the 
nmr tube, the subsequent spectra no longer showed this abnormality in the extracellular 
peak, presumably due to the replacement of the decomposed PsOio^”. The 3lp spectra 
recorded prior to, and subsequent to the nmr experiment of the cells in the growth 
medium are shown in Figure 2.4A and 2.4B, respectively. The spectra are very similar 
indicating no significant changes in either the phosphorous metabolites or the 
intracellular pH, thus confirming the viability of the cells and, therefore, the 
experiment.
The viability of the cells was also confirmed by assay of the inositol uptake 
behaviour using [3H]-inositol by Dr I. Batty of the University of Dundee (8). This 
assay also gave an approximate value of 80mg protein (4 x 10  ^cells) per ml beads 
packed under gravity.
2 .2 ,3  Determination of Intracellular [Li+] in Astrocytomas
A very approximate value for the intracellular [Li+] was determined from the 
nmr data on the astrocytoma samples, by establishing an approximate value for the 
intracellular volume as a percentage of the sample volume. This method assumes no 
loss of nmr-visibility for any of the 33Na-, or the ^Li-nmr resonances and assumes an 
intracellular [Na+] of 20mM (9),
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Figure 2.4 31p nmr spectra of human 1321 NI astrocytomas on microcanier beads 
recorded prior to (A), and subsequent to (B) a Li+-nmr experiment
(1 PE; 2 PC; 3 Pi; 4 GPE; 5 GPC; 6 PCr; 7 y-NTP; 8 a-NTP; 9,10 UDPG;11 P-NTP { I ) )
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The integral of the Na+ resonance from the reference spectrum of the buffer is 
set at 100. Therefore, the percentage volume occupied by the buffer (VNa-out) iit the 
suspensions of beads/cells is given by the integral of the extracellular Na+ resonance 
(iNa-out)- The intracellular Na+ at 20mM occupies a percentage volume VNa-in» and 
gives a signal of integral I^a-in, where:
iNa-m -  iNa-out x x
and since VNa-out = iNa-out, the intracellular volume is given by:
VNa-in = iNa-in x
Using this value, the [Li+]in was determined from the [Li+]out and the integrals of the 
intra-, and extracellular resonances in the corresponding ^Li-nmr spectmm by:
The volume occupied by the beads is given by: 100 - (Vin + Vout)-
2 ,3 .1  Rats for in vivo "^Li-Nmr Spectroscopy
Sprague-Dawley rats weighing approximately 250g were provided by 
SmithKline Beecham Research Ltd and were handled by Dr D. Reid. The rats were 
administered doses of LiCl, varying from l-5mmol.kg‘t, by intraperitoneal (i.p.) 
injection prior to the nmr experiment. Repeat dosages were administered to some 
animals at intervals over 1 or 2 days, to allow accumulation of Li+ in tissues and 
organs. The rats were anaesthetised with a barbiturate (Sagital) administered i.p. 
before being secured in a purpose built holder to maintain the animal in a fixed vertical 
position within the magnet. The contrast reagents were introduced into the bloodstream 
by intravenous (i.v.) injection into the tail vein. The rats were sacrificed after the 
experiment.
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2 .3 .2  In vivo Nmr Spectroscopy of Rat Brain
In vivo ^Li-, and 3lp-nmr spectra were recorded using a Bruker AM360 
spectrometer at 139.960 and 145.785 MHz, respectively. A surface coil, which could 
be retuned without moving the rat, was positioned on the surface of the scalp. The 
homogeneity of the magnetic field was adjusted using the signal from the rat brain. 
For ^Li-nmr spectra, 100-1000 FID's were collected into IK data points with a sweep 
width of 5000Hz (9.76 Hz/pt), and were transformed in 8K (1.22Hz/pt) with a line- 
broadening of 25Hz. In order to keep the acquisition time as a short as possible, a 
repetition rate of typically 2s was employed. Although the relaxation times were not 
determined, this delay is probably insufficient for full relaxation of all the Li+ species 
present; a Ti in rat brain of 4.1s has previously been reported (10). This was 
demonstrated in a study using interpulse delays of 0, 2 and 5s which gave relative 
integrals of 4.6, 8.4 and 1.0. Therefore no quantitative data could be obtained from 
this data. For 3lp-nmr spectra, 512 FID's were collected into 2K data points with a 
sweep width of 8000Hz (7.81Hz/pt) and a repetition rate of 4s, giving an acquisition 
time of 34min. The FID's were transformed in 8K (1.95Hz/pt) with a line-broadening 
of 15Hz. 3lp-nmr spectroscopy was employed to monitor the metabolic state of the 
rats. A typical spectrum from a healthy anaesthetised rat is shown in Figure 2.5.
2 .4  Extraction and Separation of Erythrocyte Membrane Lipids
The extraction of the lipids from erythrocyte membranes and their subsequent 
separation by high-performance, thin-layer chromatography (HP-TLC) was based on a 
method used at the NERC unit, University of Stirling (11). The lipid extraction is 
adapted from a procedure described by Folsch (12) and the HP-TLC of the lipids is as 
according to Vitiello (13).
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Figure 2.5 /n v/vo^^P nmr spectrum ofthe head of an anaesthetised rat 
(1 PME; 2 Pi; 3 PCr; 4 y-NTP; 5 a-NTP; 6 P-NTP (7 O»
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2 .4 .1  Extraction of Lipids from Erythrocyte Membranes
The following extractions were performed in duplicate. Erythrocytes were 
isolated from the venous blood of healthy volunteers and of Li+-treated psychiatric 
patients, as described previously in Section 2.1.2, and an aliquot of gently packed 
erythrocytes in aqueous medium (0.5ml) was transferred to a glass-stoppered 
centrifuge tube (15ml) for lipid extraction. The erythrocyte membranes were disrupted 
by repeated freeze-thawing (3 times). H2O (0.5ml) and CHClg-MeOH (2:1), with an 
antioxidant, butylated hydroxy-toluene (BHT, 0.01%w/v), (8ml) were added to the 
tube. The mixture was shaken vigorously and then left on ice for Ih, with intermittent 
shaking. KCl (0.88%w/v, 1ml) was then added and the mixture was shaken before 
being centrifuged to separate the 2 phases. The aqueous phase (upper) was removed 
gently by pipette and the organic phase (lower) was then filtered though a prewashed 
filter (Whatmans N° 1). The residue was rinsed with CHClg-MeOH (2 x 1ml) and the 
combined filtrates were brought to dryness under a stream of N2. The lipids were 
immediately resuspended in CHClg-MeOH (1ml), transferred to a weighed sample 
bottle, dried under N2 and desiccated in the dark for 30min. The weight of lipid was 
determined before being resuspended in CHClg-MeOH (l%w/v) and stored at -5°C 
under N2 until required. A further aliquot of packed erythrocytes from the same sample 
(0.1ml ) was transferred to a volumetric flask (50ml) which was filled to the mark with 
isotonic buffer. The cells were then counted using a haemocytometer (B.D.H.).
2 .4 .2  Thin-Layer Chromatography of Erythrocyte Membrane
Lipids
HP-TLC plates (Merck, pre-coated silica gel-60, 10 x 10cm) were prerun with 
CHCl3-MeOH (2:1) and then desiccated. The plates were activated at 110“C for 
30min. prior to use. Lipid extracts (approximately lOjig) were applied, as a small 
horizontal line (-), 1cm from the bottom of the plate and ascending chromatography
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was then performed at room temperature with the first solvent system: chloroform - 
i-propanol - methyl acetate - methanol - 0.25% w/v KCl (25 : 25 : 25 : 10 : 9) until the 
solvent front had travelled for approximately 5cm. The plate was then transferred to a 
desiccator for 30min. Chromatography was then performed in the same direction to 
within 0.5cm of the top of the plate, using the second solvent system: hexane - diethyl 
ether - acetic acid (80 : 10: 2). The plate was dried in air and the lipids were revealed 
by spraying with a solution of cupric acetate (3% w/v) and phosphoric acid (8% w/v) 
and charring at 160'C for 15min. This produced simultaneous detection of all the lipids 
as black spots. The plates were stored in foil and analysed by a flying-spot, scanning 
densitometer (Shimadzu CS-9000) as soon as possible (within 1 day) as the spots 
faded very quickly.
2 .5  Solubilisation and Separation of Erythrocyte Membrane
Proteins
The solubilisation of the proteins from human erythrocyte membranes using 
sodium dodecyl sulphate (SDS) and the subsequent fractionation by polyacrylamide gel 
electrophoresis (SDS-PAGE) was based on the method of Laemmli (14).
2 .5 .1  Preparation of Protein Samples
Erythrocytes were isolated from the venous blood of healthy controls and of 
Li+-treated psychiatric patients, as described in Section 2.1.2. Gently packed 
erythrocytes ^ n^queous medium (2ml ) were lysed by adding ice-cold Tris/HCl (20ml, 
20mM, pH 7.4) containing EDTA (ImM), and leaving on ice for lOmin. The cells 
were then centrifuged at 16000rpm for 20min. (Beckman J2-21 centrifuge with JA 20 
rotor) after which the supernatant was aspirated. The residual pellet was washed 8 
times in the lysis buffer followed by centrifugation and aspiration of the supernatant, to
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produce white erythrocyte ghosts containing no cytosolic material. The ghosts were 
stored at -20°C until required. The following solubilisation and fractionation was 
performed in duplicate. Aliquots of the ghosts (lOOpl) were diluted with SDS-PAGE 
sample buffer (400jJ,l) and heated in a boiling water bath for 5min. The SDS-PAGE 
sample buffer contained: H2O (4ml), Tris/HCl (1ml, 0.5M, pH 6.8), glycerol (0.8ml), 
SDS (1.6ml, 10%), 2-mercaptoethanol (0.4ml) and bromophenol blue (0.2ml, 0.05% 
inH20).
2 .5 .2  SDS-PAGE of Erythrocyte Membrane Proteins
The separating gel (7.5% monomer) was prepared from acrylamide/bis (25ml, 
from acrylamide (146g) and N'N'-bis-methylene-acrylamide (4g) in H2O (500ml)), 
Tris/HCl (25ml, 1.5M, pH 8.8), SDS (1ml, 10% in H2O), H2O (48.5ml) and 
N,N,N',N'-tetramethylethylenediamine (TEMED, 50pl). Polymerisation was initiated 
by the addition of fresh ammonium persulphate (AMPS, 500|iil, 10% in H2O) and the 
solution was poured into the prepared glass plate sandwich. Butan-l-ol (0.5ml) was 
carefully layered onto the gel surface to exclude atmospheric O2 which inhibits the 
polymerisation. After 45min. the butanol was removed and the surface of the gel was 
rinsed with H2O.
The stacking gel (4% monomer) was prepared from acrylamide/bis (1.3ml), 
Tris/HCl (2.5ml, 0.5M, pH6.8), SDS (lOOpl, 10%), H2O (6.1ml) and TEMED 
(lOjXl). Polymerisation was initiated by the addition of AMPS (50pl, 10%) and the 
solution was applied to the top of the polymerised separating gel. A 15-place teflon 
comb was inserted into this solution to produce 15 sample wells on polymerisation. 
The final gel was 16cm long and 0.75mm thick.
The samples were applied to the gel such that there was an equal protein loading 
in each lane. The gels were then run under constant current, using 30mA for the
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stacking gel and 50mA for the separating gel, in the running buffer: Tris base (25mM), 
glycine (192mM) and SDS (0.1%). Once the bromophenol blue tracker dye had 
reached 5mm from the bottom of the gel (~3h), the current was switched off and the gel 
was immersed in the staining solution, Coomassie brilliant blue R250 (prepared from 
Coomassie blue (Ig) dissolved in methanol (500ml), followed by the addition of glacial 
acetic acid (100ml) and H2O (400ml)). The gel was stained for 30min. and then 
washed in destaining solution (prepared from methanol (500ml), glacial acetic acid 
(100ml), and H2O (400ml)). The gel was then dried onto filter paper or photographed.
2 .6  '^Li-Nmr Spectroscopy of Interaction of L1+ with Inositol
Monophosphatase
Bovine brain inositol monophosphatase was supplied by Dr A. Leech, 
University of St. Andrews. ^Li-nmr spectroscopy of inositol monophosphatase was 
performed using a Bruker MSL500 spectrometer fitted with a solenoid probe. This 
gave higher sensitivity (approximately 2.5 times) than the high resolution probe at the 
expense of the resolution. Sample tubes, specially adapted from standard 5mm nmr 
tubes, were made in order to contain a small sample volume (200-250pl), and which 
could be secured in a horizontal position within the detection coils of the probe. The 
homogeneity of the magnetic field was adjusted using the 3lp signal from H3PO4, after 
which the homogeneity was not altered for the remainder of the experiment. For the 
^Li-spectra, typically 200 FID's were collected with a sweep width of lO^Hz. 
Aqueous solutions of homogeneous bovine brain inositol monophosphatase (0.2- 
0.3mM) containing K+ (250mM), Mg2+ (3mM) and Tris (50mM) at pH 7.5, with 
varying concentrations of LiCl, inositol 1-phosphate, HPO42-, and Dy(P30io)2^' (from 
DyCl3 and K5P3O10) were investigated by ^Li-nmr spectroscopy. Ti values were 
determined using the standard inversion-recovery method (3),
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2 .7 .1 Chemical Shift of the l^^Cs-Nmr Resonance
133cs-nmr spectroscopy was performed at either 39.4MHz or 65.6MHz using 
the Bruker AM300 or MSL500 spectrometer, respectively. The chemical shift of the 
I33cs resonance in various aqueous solutions was investigated to find a suitable 
solution for the incubation of the erythrocytes for Cs+ uptake experiments and the 
results are shown in Table 2.2. The dramatic effect of phosphate anions on the 
chemical shift of l^^Cs has been observed previously (15), however the largest shift 
observed here was in the solution containing no phosphates. Solution 1; the only anion 
in this solution was Cl". In suspensions of erythrocytes, the chemical shift difference 
between the intra-, and the extracellular Cs+ resonances produced by Solutions 1, 2 and 
4 in Table 2.2 were 0.94ppm, l.OSppm and Oppm, respectively. Therefore, in order to 
allow the incubation medium to be buffered, solution 2 was employed in the following 
Cs+ uptake experiments.
Table 2.2 The chemical shift of 133(Zs resonance in various aqueous solutions*,
Solution P043-/mM PsÛio^'/mM Mg2+(Ca2+)/mM 8/ppm
1 0 0 0 -5.87
2 4.75 0 0 -5.69
3 0 15 0 -3.76
4 4.75 15 1(2) -4.66
^solutions all contain 130mM Na+, 7mM K+, lOmM Cs+ and lOmM dextrose
2 .7 .2 Cs+ Uptake into Human Erythrocytes
Venous blood (20ml) was drawn from healthy volunteers and from patients 
from the alcoholism clinic at the Ninewells Hospital, Dundee, and the erythrocytes
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isolated as in Section 2.1.1. The erythrocytes were incubated in an isotonic medium 
(115mM NaCl, 20mM KCl, 4.75mM Na3P04 and lOmM dextrose, pH 7.4) until 
required for an experiment. At the start of an experiment the incubating medium was 
changed to a Cs+-containing buffer (115mM NaCl, lOmM KCl, lOmM CsCl, 4.75mM 
Na3P04, and lOmM dextrose, pH 7.4).
I33cs nmr spectra were recorded and the intracellular [Cs+] concentrations were 
determined using the same methods employed in the study of Li+ in erythrocytes in 
Section 2.1.5. Typically, 8 FID's were collected into 2K data points with a sweep 
width of 2000Hz (1.95Hz/pt) and a repetition rate of 60s. The FID's were transformed 
in 8K (0.49Hz/pt) with a line-broadening of 5Hz.
2 .7 .3  ^^Na-, and 39K-Nmr Spectroscopy of Erythrocytes
Quantitative ^^Na-, and 39K-nmr spectroscopy was employed to monitor the 
change in the intracellular concentrations of these cations, in erythrocytes incubated in 
isotonic medium containing increasing concentrations of Cs+. A sample of 
erythrocytes, isolated as in Section 2.1.1, was divided equally into 5 and each aliquot 
was incubated overnight at ambient temperature in one of the Buffers A-E in Table 2.3.
Intracellular Na+ concentrations were determined by the same methods 
employed in the ^Li-nmr spectroscopy of erythrocytes in Section 2.1. However under 
these conditions, the intra-, and the extracellular K+ resonances were not resolved and 
the intracellular K+ concentrations had to be determined by difference spectroscopy. 
The spectra from the erythrocyte samples were subtracted from that of the 
corresponding buffers such that the extracellular K+ signal disappeared leaving just the 
intracellular signal, of integral lin. This produced a subtraction factor which was used 
to determine the haematocrit of the sample. lin was subtracted from the integral of the 
total original signal to give the integral of the extracellular signal, lout- The intracellular
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concentrations were then determined using the same calculations as for Li+, in Section 
2.1.5.
The values obtained for Na+ and K+ are not absolute since the reported nmr 
invisibility of these cations was not considered. However, in this study only the 
change in the intracellular concentrations was investigated.
Table 2.3 The composition of the aqueous buffers
Buffer [NaCl]/mM [CsCl]/mM
A 70 0
B 60 10
C 45 25
D 20 20
E 0 70
*buffers all contain 15mM KCl, 4.75mM NagPO^, lOmM dextrose, lOmM NagPsOio,and 2.5mM DyClg
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Chapter 3
Lithium NMR Spectroscopy of Erythrocytes
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3.1 Li Nmr Spectroscopy
Both of the naturally occurring isotopes of lithium, % i and ^Li, are nmr visible. 
Table 3.1 shows the nuclear properties relevant to nmr spectroscopy of both isotopes of 
lithium compared to the other alkali metals. The relatively high sensitivity of ^ Li, its 
small quadrupole moment (Q), and its high natural abundance are all conducive to the 
relatively facile study of ^ Li by nmr. The very small values of Q for both isotopes (%i 
has the smallest known Q) means that quadrupolar relaxation mechanism is relatively 
inefficient in these nuclei and therefore the relaxation tends to be dominated by the 
dipolar mechanism.
Table 3.1 Nuclear properties of the alkali metals (1)
Nucleus ^Li ^^Na 133Cs
Natural Abundance (%) 7.4 92.6 100 93.1 100
Spin Quantum Number 1 3/2 3/2 3/2 7/2
Quadrupole Moment 
(10-28m2)
-0.0008 -0.045 0.12 0.055 -0.003
Frequency(MHz)* 14.72 38.87 26.48 4.67 13.21
Receptivity^ 3.58 1540 525 2.69 269
(* relative to = 100 MHz, t relative to = 1)
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3 .1 .1  Shift Reagents for Studying Membrane Transport of Li+
Several techniques using shift reagents can be employed to study the transport 
of cations across membranes and the choice of method depends on the time-scale of the 
process under study: dynamic line-broadening is used for very rapid processes (where 
the rate is > 5s"l), however no Li+ transport process has yet been observed that is fast 
enough for study by this method; magnetisation transfer is used for slower process 
which are on similar time-scale to the nmr relaxation times (rate < 5s’l for ^ Li): and, for 
very slow processes, the signal intensities can be measured as a function of time. The 
latter method has been employed to study the relatively slow transport of Li+ across the 
erythrocyte membrane.
3 .1 .2  Li-Nmr Spectroscopy for Transport Studies in Erythrocytes
The identification of Dy(P30io)2^" as a shift reagent for the alkali metals led to 
the development of ^Li-nmr studies of isolated erythrocytes incubated in lithium 
containing media. For typical [Li+] found in the blood plasma during lithium therapy 
(i.e. 0.5 - 1.2 mM), a concentration of 5mM Dy(P30io)2^" was found to be sufficient 
to resolve the signals from the intra-, and the extracellular Li+ producing a chemical 
shift difference of approximately 4ppm (2). At this concentration of Li+ and shift 
reagent the signals were still resolved by approximately 3ppm in the presence of 
physiological concentrations of other cations which compete with Li+ for the shift 
reagent (Na+, K+, Mg^+ and Ca^+) (3),
Using Dy(P30io)2^"j a few studies on the transport of Li+ across the 
erythrocyte membrane have been carried out, initially using high concentrations of Li+ 
in order to obtain adequate signal-to-noise. Quantification was usually achieved by 
comparing the integrals of the signals from the erythrocyte samples relative to that from 
a reference sample. The integrals of the signals were monitored as a function of time.
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For efflux measurements, the erythrocytes were usually preloaded with Li+ by 
incubating overnight in a medium containing a high, non-physiological [Li+]. In 
general, it was found that the uptake of Li+ is a slow process in erythrocytes and very 
little Li+ is taken up relative to the concentration in the extracellular medium, as 
observed in the previous studies using A AS.
Li+ uptake into erythrocytes from a medium containing 50mM Li+ (25’C, 5mM 
Dy(P30io)2^") followed single-exponential kinetics with a time constant of 14.7±1.2h, 
and the efflux of Li+ from erythrocytes into a Li+-free buffer at 25“C (preloading with 
Li+ by incubating in 50mM LiCl for 24h, 37"C) was found to be extremely slow 
(approximately 1% per h) (4). Similar uptake kinetics, with a time constant of 16.5h, 
were observed at 50mM Li+ (85% haematocrit, 25'C, 5mM Dy(P30io)2^‘) whereas a 
time constant of 11,6h was observed under more physiological conditions (l.SmM Li+, 
45% haematocrit, 37'C, 5mM Dy(p30io)2^ ’) (5).
In another study, the uptake of Li+ into erythrocytes incubated in a buffer 
containing 34mM Li+ was slow with very little Li+ entering the cells compared to the 
extracellular concentration (6). The uptake was linear over the time period studied (Ih) 
with no evidence for saturation of the intracellular [Li+], A similar experiment using 
40mM Li+ showed that the [Li+] entering the erythrocytes was only approximately 10% 
of the [Li+lout (7). The uptake of Li+ into erythrocytes at a more therapeutically 
relevant [Li+]out (2mM) was followed for 33h (8) and appeared to follow first order 
kinetics with a rate constant of 3.33 x 10'^ min-l. After 24h the [Li+]in was only 
0.34mM giving a value for the [LriJin /  [Li+jout ratio of 0.17, confirming the reluctance 
of erythrocytes to take up Li+ to any extent. After 24h, half the erythrocytes were 
resuspended in a buffer containing 2mM ^Li+ instead of 2mM ^Li+, and the [^Li+]in 
was seen to decrease very rapidly. This was ascribed to a ^Li+ - %i+ exchange rate 
which was approximately 16 times faster than the rate of ^Li+ uptake. In this 
experiment the Li-nmr spectra were recorded with a 44s delay between 90' pulses, thus 
obtaining the maximal signal intensity with full relaxation between pulses. Using
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extracellular concentrations of lOOmM for both isotopes, the uptake of %i+ into 
erythrocytes was significantly faster than that of 7Li+, with rates of 1.56 ± 0.12 and 
1.32 ± 0.14 mmol.Li+ (1 cells)"lh-l and rate constants of (6.92 ± 0.57) x 10"^  h-l and 
(5.93 ± 0.64) X 10’^  h-l respectively (9).
3 .1 .3  Relaxation Behaviour of Li+ in Erythrocytes
The Ti and T% values for 7Li+ blood plasma are of the same order of 
magnitude, that is 4.89±0.49s and 2.93±0.09s respectively. However, the Ti and T2 
values for intracellular 7l1+in suspensions of erythrocytes are 5.10±0.56s and 
0.145±0.02s, respectively, all values being determined at 25°C (4), The significantly 
shorter T2 inside the erythrocytes indicates the presence of some interaction with a long 
correlation time. Binding of Li+ to haemoglobin does not appear to be a contributory 
factor as the interaction is very weak or nonexistent; the 2 relaxation times for Li+ in 
solutions containing both LiCl and isolated haemoglobin are of the same order of 
magnitude (4). The short T2 inside the erythrocytes was, therefore, proposed to be due 
either to the relative immobilization of Li+ by the intracellular membrane-associated 
cytoskeleton, or to the slow diffusion of Li+ through the heterogeneous electrostatic 
field gradients produced by the cytoskeleton (4).
3 .1 .4  LÎ+ Transport in Erythrocytes by the Inversion-Recovery
Method
A further method for studying Li+ transport in erythrocytes by Li-nmr 
spectroscopy uses the natural differences in the Ti relaxation times between intra-, and 
extracellular Li+ using an inversion-recovery pulse sequence. The pulse sequence is 
designed such that no signal is observed from the Li+out where T% is long
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(approximately 20s in the absence of shift reagent), and that all the signal is observed 
from the Li+in where Ti is much shorter (5s). The pulse sequence employed is:
D -180" - Di - 90"
where D is a long delay to ensure the complete relaxation of the magnetizations of both 
the Li+in and Li+outî the 180" pulse inverts the magnetisation of both onto the -z axis; 
Di is a delay which is chosen to allow partial relaxation of Li+out signal such that, 
when the 90" pulse is applied, the component of magnetisation of the Li+out along the 
y'-axis is negligible and no signal is detected, and the relaxation of the Li+in is such that 
the maximum signal can be detected by the 90" pulse. Extreme care has to be taken 
with this method to ensure that accurate values for Ti are obtained and, since Ti is 
temperature dependent, the temperature of the samples during spectral acquisition has to 
be controlled. This ensures that the signal from Li+out in samples of erythrocytes will 
be nullified by the pulse sequence and will not contribute to the signal measured for the 
Li+in. The advantage of this method is that it does not involve the use of shift reagents 
which, by their very nature, have the potential to interfere with the transport of the 
cations under investigation.
A modified inversion-recovery method (MIR) was first employed to study 
intracellular 39k+ (10), and this was recently applied to the study of Li+ transport in 
erythrocytes (11,12), This modified pulse sequence employed a 60" instead of a 90" 
pulse, giving a faster repetition rate, and the delays used for ^Li+ were 60.0 and 11.5s, 
for D and Di respectively. This value of Di provided only partial relaxation of the 
Li+in resonance and resulted in only 81% of the maximum possible signal for Li+in. 
After preloading a sample of erythrocytes with Li+, the efflux of Li+ into a choline- 
containing medium, due to passive transport, and into a Na+-containing medium, due 
to both passive transport and to Na+-Li+ exchange, was investigated by this method. 
The difference between the two rates was taken as being due to the Na+-Li+ 
countertransport alone and the rates determined by this method were compared with
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those obtained using shift reagents in Li-nmr spectroscopy and by A AS (Table 3.2) 
(11). The rates determined by MIR were virtually identical to those obtained by using 
either the shift reagent Dy(TTHA)3- or by AAS, however those obtained using the shift 
reagent Dy(P30io)2^“ were significantly higher. Similarly, the steady-state ratio 
[Li+Jin /  [Li+]out was found to be similar using the MIR method, Dy(TTHA)3- and 
AAS (0.35+0.02,0.36±0.02 and 0.3610.02 respectively) whereas with Dy(P30io)2^% 
the ratio was higher (0.4810.03) (12). This discrepancy was attributed to a significant 
amount of extracellular Li+ complexing with the highly negatively charged 
Dy(p30io)2^ % resulting in the altered transport rate; this problem was not experienced 
with the lower charged, Dy(TTHA)3-.
The MIR method also demonstrated the use of non-invasive nmr techniques to 
compare the Li+ transport rates in erythrocytes from patients suffering from either 
bipolar disorder or hypertension and from healthy control subjects (11,13). The Na+- 
Li+ countertransport rate in erythrocytes was significantly higher in the hypertensive 
patients, and lower in the bipolar patients than in the controls (Table 3.2), with rate 
constants of 0.611 O.Olh-l for the hypertensives and 0.18 1 O.Olh'l in the controls 
( 14). In a similar study the Na+-Li+ countertransport rates in erythrocytes from a 
group of psychiatric patients on lithium therapy were compared to those of healthy 
controls (15). The patients studied were suffering from either schizo-, or bipolar 
affective disorder and none were hypertensive. The Na+-Li+ countertransport rates 
were significantly lower in the patient group (0.13 ± 0.02mmol.Li+(l cells)-lh-l) 
compared to the controls (0.23 ± 0.03mmol.Li+(l cells)‘ih"l) and also the rate constants 
were significantly lower for the patient group (0.12 ± 0.04h"l compared to 0.24 ± 
O.Olh-1). This effect on the Na+-Li+ countertransport rates in erythrocytes was thought 
to be a direct consequence of the lithium therapy of these patients.
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Table 3.2 Comparison of the methods for determination of the Na+-Li+ 
countertransport rates in erythrocytes from psychiatric patients and healthy controls
TECHNIQUE CONTROL BIPOLAR HYPERTENSIVE 
(n=10) (n=12) (n=10)
AAS
NMR/MIR
NMR/Dy(P30io)2'^"
NMR/Dy(TTHA)3-
0.20 ± 0.03 0.14 ± 0.03 0.53 ± 0.02 
0.21 ± 0.02 0.13 ± 0.04 0.51 ± 0.04 
0.34 ± 0.04 
0.22 ± 0.02
3 .1 .5 lonophore-Mediated Li+ Transport in Erythrocytes
lonophores are compounds which increase the permeability of membranes to 
ions by forming complexes with the ions. The movement of Li+ across membranes, 
mediated by ionophoric antibiotics has been demonstrated using phospholipid vesicles 
as model systems (16,17,18,19).
After preloading a sample of erythrocytes with Li+ by incubating overnight in a 
buffer containing 150mM LiCl, the ionophore-induced efflux of Li+ into both K+-, and 
Na+-containing media (with 5mM Dy(P30io)2^ '), was followed by Li-nmr (3). With 
the ionophore monensin, Li+ transport into a K+-medium followed first-order kinetics 
dependent on the [monensin], whereas when the K+ was replaced by Na+ in the 
medium, no Li+ transport was observed since monensin has a much higher affinity for 
Na+ than for Li+. Two cryptands were also tested as potential Li+ ionophores, C221 
(4,7,13,16,21 -pentaoxa-1,10-diazabicydo[8.8.5]tricosane) and C211 (4,7,13,19- 
tetraoxa-1,10-diazabicyclo[8.5.5]eicosane), however these induced only a very slight 
increase in Li+ transport compared to the unfacilitated Li+ efflux found in the absence 
of ionophores (3,20). It should be noted that in these experiments the interpulse delay
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was only 7.5 s (only 1.5 x Ti for the intracellular Li+ resonance) and, although only a 
45“ pulse was applied, this is not thought to be sufficient for full magnetic relaxation. 
Therefore the absolute values for the [Li+] must be treated with caution. Additionally, 
the transport is dependent upon the rates of association and dissociation of the 
cation donophore complex; C221 and C211 form relatively stable Li+ complexes such 
that the dissociation rate is relatively slow, resulting in slow transport.
3 .1 .6  Li-Nmr Visibility
For all these quantitative studies it is essential to know whether the integrals of 
the Li+ resonances observed represent the actual [Li+] present in the sample. The 
presence of a pool of slowly exchanging Li+ which is subject to either a strong 
quadrupolar interaction, or to a low quadrupolar interaction with a long correlation time 
(if the molecule is tumbling slowly) will lead to a reduction in the nmr visibility. This 
effect has been observed in the 73Na-nmr spectra for intracellular Na+ in erythrocytes 
where only 80% of the Na+in present is actually nmr-visible (21 ). In one study all the 
Li+ present in the nmr samples was reported to be nmr visible and, after lysing the 
erythrocytes to remove all the solubilized Li+, no membrane-associated Li+ was 
observed by Li-nmr (4).
One method to assess the nmr visibility is to compare the values obtained by 
nmr with those obtained by other analytical techniques, such as AAS. However, for 
intracellular species, these techniques generally involve physical separation and 
washing of the cells, and great care is necessary to avoid the loss of any of the Li+ 
during the procedure. By this method Hughes (7) found the values for the [Li+]out 
were very similar by the two techniques, but the values for [Li+]in determined by Li- 
nmr were 2-4 times smaller than those determined by AAS. This discrepancy was 
attributed to invisibility of some of the intracellular Li+ due to binding to the cell 
membranes and/or to intracellular components. However the nmr spectra for both the
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above experiments were recorded using only a 6s interval between die 45“ pulses which 
is probably not sufficient for full relaxation of the intracellular Li+ (Ti ~ 5s (3,4))\ this 
would result in a lower signal intensity and correspondingly lower values for pLi+lin*
A method involving comparison of the integrals of the nmr resonance from Li+ 
in intact cells to that after the cells have been treated with detergent has also been 
employed (12), The detergent was used to solubilize the membrane and thus free any 
membrane associated Li+ and it was found that there was no invisibility in the Li+ 
signal from the intact erythrocytes. This data is in contrast to that reported by Gullapalli 
et al, who compared the integrals of the signals from Li+ in packed erythrocytes, of 
known total [Li+], to the signals from Li+ in solutions of LiCl at the same 
concentrations (5). The results are shown in Table 3.3 and show that at levels typically 
observed in blood plasma during therapy the nmr visibility of ^Li+ is reduced to ca. 
85%. A comparison of the nmr results for both intra-, and extracellular [Li+] with 
those determined by ICP-AES showed the same visibility for both compartment. AAS 
analysis showed that very little Li+ (1%) remained in the cell fragments produced by 
lysing and repeated washing of the erythrocytes indicating that the reduced visibility is 
probably not attributable to any strongly bound Li+. In this work, however, no loss of 
signal intensity of the Li+ resonances was experienced from the samples of packed 
erythrocytes when compared to those from aqueous solutions containing the same 
concentrations of LiCl (Section 2.1.4), in agreement with Mota de Freitas et at (12).
Table 3.3 Variation in ^Li-nmr visibility with [Li+] in erythrocyte samples (15)
[Li+]/mM 40 10 5 1
Visibility/% 97 92 86 84
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3 .2  Li+ Uptake into Erythrocytes Using ^Li-Nmr Spectroscopy
In this study, the uptake of Li+ into human erythrocytes was monitored in vitro 
by isolating erythrocytes from whole blood and resuspending them at 37"C in an 
isotonic medium containing 2mM Li+ - a concentration only slightly higher than that 
found in the blood plasma during lithium therapy. The medium was designed to 
maintain the viability of the erythrocytes and their transport functions. The 
concentration of Li+ in the extracellular space was kept constant at 2mM and the 
intracellular concentration was determined by quantitative ^Li nmr spectroscopy. 90“ 
pulse width measurements and Tj determinations for ^Li were carried out to ensure that 
both the maximum signal intensity and full magnetic relaxation between pulses for all 
Li+ species present was achieved. The Tj values for all the Li+ species encountered in 
this work are shown in Table 3.4.
The longest Tj in the erythrocyte samples was 5.75±0.08s due to the 
intracellular Li+ and is comparable to the reported values of 5.10±0.56s (4) and 
5.7±0.06s (5). Therefore, for valid quantification of the [Li+] in the following 
experiments, an interpulse delay of 30s ( > 5 x Ti) was employed to ensure complete 
relaxation of all the Li+ species. The aqueous shift reagent, Dy(P30io)2^‘ (from 
0.5mM Dy3+ and 15mM P30 io^") was included in the incubating buffer ; at this 
concentration, the chemical shift difference between the nmr resonances from the intra-, 
and the extracellular Li+. was typically 0.6ppm and the line widths at half-height were 
typically 20Hz and lOHz, respectively.
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Table 3.4 Cûi/2 and T% values for the various Li+ species encountered during the
Li+-Containing Medium CO1/2 /HZ T iV s
LiCl (2mM) 2 18.66 ± 0.10
Buffer B (2mM Li+) 4 0.408 ± 0.006
Buffer B (in samples of packed 
erythrocytes)
12-18 0.319 ± 0.004
Blood plasma (0.4mMLi+) 10.34 ± 0.38
Erythrocytes, intracellular (after 18h 
incubation in Li+-ffee media)
8 -10 5.679 ± 0.026
Erythrocytes, intracellular (after 24h 
incubation in buffer B at 37'C)
8-10 5.754 ± 0.083
*Ti values are from single determinations using the inversion-recovery technique
3 .2 .1 '^Li+ Uptake Into Erythrocytes from Healthy Controls
The blood from a healthy volunteer from within the chemistry department was 
obtained and the erythrocytes were isolated and resuspended in Buffer A until required. 
After resuspending in Buffer B and incubating at 37“C, the uptake of Li+ into the 
erythrocytes was followed with time. Figure 3.1 shows a series of ^Li nmr spectra 
from a typical experiment. The spectra of the erythrocytes show two signals, one at 
-0.64ppm assigned to the extracellular Li+ ((O1/2 = 22Hz) and one at Oppm assigned to 
the intracellular Li+ (CÛ1/2 = lOHz). The chemical shift of the resonance from the 
intracellular Li+ is identical to that observed in the absence of shift reagent and does not 
change over the course of the experiment, confirming that the shift reagent does not
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Incubation Time /min.
0.102 636
0.095 428
0.067 336
0.058 246
0.000
1 . 0 0 . 0 1. 0 “ 2 . 0PPM
Figure 3.1 ^Li-nmr spectra of human erythrocytes incubated in Buffer B 
(containing 2mM Li+) showing time dependence of the intracellular [Li+] 
(Each spectrum is the sum of 100 acquisitions recorded at 194MHz on the MSL500
nmr spectrometer)
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penetrate the erythrocyte membrane under the conditions used. The chemical shift of 
the resonance from the extracellular Li+ is also unchanged throughout the experiment 
confirming that the pH of the extracellular medium remains constant; the chemical shift 
induced by Dy(P30xo)2^’ is very pH dependent at physiological pH {22). The signal 
from the intracellular Li+ increases in intensity with respect to time and, from the 
integrals of the peaks, the haematocrits of the samples and the corresponding 
intracellular Li+ concentrations were calculated.
The experiment was repeated several times with erythrocytes from a number of 
healthy individuals and the results obtained were very similar. The time dependence of 
the [Li+lin from a typical experiment is shown in Figure 3.2A. Throughout the 
experiment the [Li+] inside the erythrocytes is low compared with the extracellular 
concentration, in agreement with previous studies of this kind; after 24h the ratio 
[Li+]in /[Li+]out is only approximately 0.06. This compares with a ratio of 
approximately 0.1 found at 40mM Li+out (7), but is lower than that observed at 2mM 
(0.17) (8). Li+out, the latter possibly due to the difference in the composition of the 
incubating medium.
3 .2 .2  '^Li+ Uptake Into Erythrocytes from Psychiatric Patients on
Lithium Therapy
Similar experiments were carried out on the erythrocytes of patients suffering 
from bipolar affective disorder and stabilised on lithium therapy. Since Li+ was already 
present in these erythrocytes as a result of the medication, the experimental protocol 
was designed to remove as much of this as possible before the uptake experiment was 
performed. The erythrocytes were incubated overnight in a Li+-free medium prior to 
the uptake experiment. However, a varying amount of intracellular Li+ persisted (0 - 
0.13mM); this was quantified by Li-nmr prior to changing to the Li+-containing 
medium for the uptake experiment. To investigate the reason for this prevailing [Li+]in,
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Tj measurements were determined for both the low [Li+]jn persisting after the 
overnight incubation in Li+-free medium and the [Li+]in accumulated after 24h 
incubation in Li+-containing medium at 37“C (Table 3.4). The Tj for any relatively 
immobilised Li+, for example due to binding to the erythrocyte membrane or to the 
cytoplasm, should be considerably shorter than that for the free aqueous Li+ in the 
intracellular water. Interestingly the two Tj values were virtually identical, inferring 
that the micro-environments of the two Li+ species were probably the same. Thus, the 
reason for the low level of Li+ remaining in the erythrocytes of the patients was not 
elucidated.
The result from a typical Li+ uptake experiment using the erythrocytes from a 
lithium-treated patient is shown in Figure 3.2B. The uptake behaviour is similar to that 
observed for the healthy individual in Figure 3.2A with a low [Li+]in compared to the 
[Li+]out over the time period studied. However after 24h, [Li+]in /  [Li+]out is higher 
than that of the healthy individual (approximately 0.08 compared to approximately 
0.06) due to the higher [Li+]in accumulated in these erythrocytes.
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Figure 3.2 The uptake of Li+ into the erythrocytes of a healthy individual (A) and a 
patient on lithium therapy for the treatment of bipolar disorder (B)
([LMout = 2mM, 3TC)
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3 .2 .3  Comparison of Li+Uptake in Erythrocytes from Psychiatric
Patients on Lithium Therapy and Healthy Controls
Using identical experimental protocols Li+ uptake experiments were then carried 
out on the erythrocytes from 11 healthy volunteers as controls, none of whom had any 
history of affective disorders or had undergone any lithium therapy, and on 9 patients 
on lithium therapy for the treatment of bipolar disorder. No attempt was made to match 
the subjects for age, sex or ethnic origin, or to control for the diet or medication of any 
of the subjects.
In both groups of people there was little variability in the uptake profiles 
between the individuals. The inter-, and intraindividual variability in the uptake of Li+ 
is demonstrated in Figure 3.3 which shows the Li+ uptake into the erythrocytes of 3 
controls (A), 3 patients (B) and 1 healthy individual on 4 separate occasions spanning a 
3-year period (C). The interindividual variability in the control group is similar to the 
variability in the repeat experiment for the single control, and is probably due to the 
experimental procedure rather than any variability in the transport processes. There is 
significantly more variation in the patient group than in the controls and obviously this 
may originate from the different levels of Li+j  ^present at the start of the experiment for 
each patient. However this behaviour may be related to the psychiatric disorder or be a 
result of the different medication regimes of the patients.
Figure 3.3C also illustrates that there is no difference in the Li+ uptake 
behaviour of the erythrocytes resulting from the two different anticoagulants used for 
collecting the blood samples in these experiments.
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Figure 3.3 Li+ uptake into erythrocytes from 3 healthy controls (A), 3 patients on 
lithium therapy (B), and 1 healthy control on 4 occasions spanning 3-years (C)
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Figure 3.4 shows a comparison of the combined results for the 12 controls and 
the 9 patients. Each data point represents the mean of the [Li+]in for all the controls 
(and patients) over 200minute periods, and the error bars comprise of both the 
biological variability and the experimental error. The amount of variability in the patient 
group is obviously greater than that for the controls. Despite the fact that the patient 
group contains an initial mean [Li+lj^ of O.OSOmM, a comparison of the two uptake 
profiles shows that the uptake of Li+ is very similar over the first few hours however, 
in the patients' erythrocytes, the [Li+ljn attains saturation after 6-8h (at approximately 
0.2mM) whereas, in the erythrocytes of the controls, the uptake is still continuing after 
24h, albeit at a reduced rate. Data was not collected for longer periods of time as the 
appearance of the suspension altered gradually, with the cells becoming darker and 
signs of haemolysis developing. It is therefore possible that these erythrocytes would 
have eventually reached the same [Lri]jn as those of the patient group.
[Li-li /^mM
0.3
0.2
0.1 #""" Controls {n=12) 
o P a t i e n t s  (n=9)
/
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0 500 1000 1500 2000
Incubation Period/min.
Figure 3.4 Comparison of the uptake of Li+ into the erythrocytes of healthy
controls and of psychiatric patients on lithium therapy 
(The error bars indicate SEM values)
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3 .2 .4  Effect of Lithium Therapy on Li+ Uptake into Erythrocytes
from Two Healthy Individuals
Two healthy volunteers (1 male and 1 female), with no previous experience of 
Li+ treatment and no personal or familial history of psychiatric illnesses, underwent a 
course of Li+ treatment (3 and 4 weeks respectively) in order to determine its the effect 
upon the uptake of Li+ into erythrocytes. For each volunteer venous blood was drawn 
prior to starting, and at weekly intervals throughout the treatment period. For each 
experiment the plasma [Li+] was determined and a Li+ uptake study carried out as 
before using ^Li nmr spectroscopy.
Lithium treatment was administered and monitored by psychiatrists from the 
Royal Liff Hospital, Dundee. Prior to the commencement of treatment, both volunteers 
underwent physical examination by the psychiatrists and their bloods were tested for 
electrolyte imbalance, for thyroid function and, in the case of the female, for 
pregnancy.
Volunteer A, a 50 year old Caucasian male, was given a daily dose of 750mg 
Li2C03 in the form of Camcolit tablets (3 x 250mg taken at regular intervals during the 
day). He reported no significant ill effects for the first few days other than a slightly 
dry mouth, thirst and increased urination. After 1 week he reported a slight nausea and 
slight cognitive impairment: he described the feeling as like having a slight hangover'. 
These symptoms lasted for another week however after 3 weeks he was no longer 
feeling any side effects. After the first week of treatment the average plasma [Li+] 
throughout the treatment period was 0.5ImM (range 0.47 - 0.58mM). The results of 
Li+ uptake experiments are shown in Figure 3.5A. Taking into account the initial 
[Li+jjn, the uptake profiles after 7 and 14 days treatment are virtually identical to that 
prior to the treatment and are similar to those observed for the healthy controls in Figure
3.4. After 24h the ratio [Li+]in /  [Li'^ ’lout approximately 0.05. However, after 21 
days the uptake profile is significantly different - the initial uptake curve is steeper and
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the [Li+] taken up by the erythrocytes is higher with [Li+]jn /  [Li+lout of approximately 
0.12 after 24h. This profile is similar to those observed for the patient group in Figure
3.4. One week after stopping the treatment a further uptake experiment was performed. 
No Li+ was found in either the blood plasma or in the erythrocytes and the uptake 
profile (not shown) was very similar to that obtained prior to the treatment; the ratio 
[Li+lin /  [Li+lout after 24h was 0.06.
Volunteer B, a 28 year old Caucasian female, was given a daily dose of 
lOOOmg Li2C03 in the form of Priadel tablets (5 x 200mg to be taken at night). She 
experienced severe discomfort during the first night and throughout the first week, with 
significant thirst and increased urination. Unfortunately, she was suffering from flu­
like symptoms when she started the treatment and became quite ill during the first 
week. After seven days she suffered bad headaches, dizziness, tinnitus and vomiting, 
and subsequently reduced the daily dose to 800mg. Any distinct side effects caused by 
the Li+ treatment were, therefore, difficult to identify. The thirst and polyuria became 
less significant but persisted at a reduced level over the next two weeks; occasional 
waves of nausea and a general feeling of lethargy were experienced throughout the 
treatment period. These symptoms disappeared after stopping the Li+ medication but 
this may also be due to coincidental recovery from the virus. The average plasma [Li+1 
determined by ISE was 0.58 after 4 days, and 0.49 (range 0.48 - 0.50) after the dose 
had been reduced. The Li+ uptake results are shown in Figure 3.5B and, taking into 
account the initial [Li+Jj ,^ there is no change in the uptake behaviour of the erythrocytes 
over the time period studied. The curves are all similar to those for the control group in 
Figure 3.4; the ratio [Li+Jj  ^/ [Li+]out was approximately 0.05 after 24h.
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Figure 3.4 The effect of lithium treatment on the Li+ uptake behaviour of 
erythrocytes from two healthy individuals (A male, B female)
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3 .2 .5  Effect of Lithium Therapy on Li+ Uptake into Erythrocytes
from Patients Suffering from Bipolar Affective Disorder
Li+ uptake behaviour was also studied in the erythrocytes of a number of 
patients diagnosed as suffering from bipolar affective disorder, when they commenced 
lithium treatment. These were all patients at the Royal Liff Hospital, Dundee under the 
supervision of the consultant psychiatrist. Dr G. Naylor.
Patient AR, a 78 year old female in-patient who had not been previously treated 
with Li+, had very rapid mood swings prior to therapy. These were significantly 
reduced after about 10 days on lithium therapy. This patient was also taking 
antidepressants. The Li+ uptake behaviour is shown in Figure 3.6A. Prior to treatment 
the uptake was very slow and was at the lower end of the range of that observed for the 
control group. There was no significant change after 4 days on Li+ therapy however a 
difference was observed after 14 days. The initial uptake was faster and a higher 
[Li+]in was attained; after 12h incubation, the ratio [Li+iin / [Li‘‘']out was approximately 
0.1 compared to only 0.06 after 4 days therapy. There was no further change in the 
uptake behaviour during the period studied; after 21 and 28 days therapy the uptake 
profiles were similar to that after 14 days with, interestingly, a very similar [Li+]^  ^
attained irrespective of the initial [Li+]j .^
Patient JD, also female, had taken Li+ previously several years ago. 
Unfortunately it was not possible to perform a Li+ uptake experiment prior to the 
patient commencing the lithium therapy. After only 4 days treatment the uptake curve 
in Figure 3.6B was similar to that observed in the patient group, however after 11 and 
25 days treatment, the accumulation of intracellular Li+ was unusually excessive, even 
for a patient, with [Li+]jn /  [Li+]out ratios of over 0.13. After 19 days treatment the 
uptake curve was almost identical to that after only 4 days. It is unlikely that these 
inconsistencies are due to non-compliance with the medication since this person was an 
in-patient at the hospital at the time of commencing lithium therapy.
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Figure 3.6 The effect of commencing lithium treatment on the Li+ uptake behaviour 
of erythrocytes from 2 patients suffering from bipolar affective disorder, who had: (A) 
never been treated with Li+ previously, (B) been treated with Li+ previously but had
not taken it for many years
84
Patient MP, a female in-patient, had taken Li+ before but the treatment had been 
stopped 6 months previously, as she was not compliant, with the medication. Li+ was 
used as a prophylactic treatment; she was also taking ECT and chloropromazine. 
Figure 3.7A illustrates that there was a very slight change in the uptake profiles after 
only 3 days therapy, and thereafter the uptake curves were very similar.
Patient BK, a female in-patient, had taken Li+ before but had stopped 5 months 
previously. This patient was depressed and showed no obvious response after 7 days 
therapy. She was also taking carbamazepine. Figure 3.7B illustrates that there was no 
change in the Li+ uptake behaviour of the erythrocytes of this patient; the uptake 
followed the pretreatment curve, even after 42 weeks therapy.
Patient CT, a 58 year old female, had previously been treated with Li+ but had 
not taken it for 8 months. She had previously had a long period of depression followed 
by acute mania and this period of Li+ therapy was started while she was suffering from 
depression in order to try to avoid the manic episode. This person was an out-patient 
and was not compliant with her medication, reducing her dosage by two-thirds soon 
after commencing the treatment. At 4,21 and 28 days, the erythrocytes of this patient 
accumulated a significant amount of Li+ (ratio of 0.13). However, after only 14 days, 
the uptake curve was similar to the pretreatment profile, possibly as a consequence of 
the patient's non-compliance (Figure 3.7C).
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Figure 3.7 The effect of commencing lithium treatment on the Li+ uptake behaviour 
of erythrocytes from 3 patients suffering from bipolar affective disorder, who had been 
treated with Li+ previously but had not taken it for: (A) 6 months; (B) 5 months; and
(C) 8 months
86
3 .2 .6  Effect of Extracellular [K+] on Li+ Uptake into
Erythrocytes
In the above studies the extracellular [K+] was 16.8mM. To investigate the Li+ 
uptake into erythrocytes at physiological [K+] similar experiments were performed at 
5mM K+ by replacing of some K+ in the incubating medium with Na+. In Figure 3.8 
the results are compared with those at 16.8mM K+ and those at a higher [K+] of 
32mM. The latter concentration was used for comparison purposes only. The uptake 
behaviour is very similar for all 3 concentrations; there is no significant difference 
between the Li+ uptake at 16.8 and 32mM K+. At 5mM K+, the [Li+]in appears to be 
very slightly higher than for the higher K+ concentrations but this only becomes 
significant after approximately lOh.
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Figure 3.8 The effect of extracellular [K+ ] on the uptake of Li+ into erythrocytes
from healthy individuals
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3 .3 Uptake of Li+ into Rat and Rabbit Erythrocytes
Using identical experimental protocols to that in the previous studies, the uptake 
of Li+ into both rat and rabbit erythrocytes was studied. The results are shown in 
Figure 3.9. In rat erythrocytes the uptake of Li+ was linear with time, with a rate of 
O.OSmM Li+h"l, no saturation was observed in the time period studied and, after lOh 
the [Li+]in was approximately 0.5mM (Figure 3.9A). This is much higher than was 
observed in any of the human studies. However, in rabbit erythrocytes, the initial 
uptake was very rapid and saturation at approximately 0.14mM Li+in was attained 
within approximately 2h (Figure 3.9B).
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Figure 3.9 The uptake of Li+ into erythrocytes of (A) 2 rats and (B) 1 rabbit
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3 .4  Discussion
The results obtained illustrate the potential for the non-invasive study of Li+ 
transport in the erythrocytes of psychiatric patients. The accumulation of Li+ in 
erythrocytes is low compared to the extracellular concentration, as observed previously 
{7J&). The higher accumulation of Li+ in the patients group in Figure 3.4 is consistent 
with the higher Li+ ratio observed for psychiatric patients on Li+ therapy, and may be 
due to the inhibition of the Na+-Li+ countertransport, the predominant mechanism of 
Li+ efflux in erythrocytes {15,23), Assuming there is no change in the two Li+ influx 
pathways in erythrocytes, the 'leak' and the anion-exchange routes, inhibition of the 
Li+ efflux pathway will result in a higher intracellular [Li+] at steady-state. 
Interestingly, in the erythrocytes of all the psychiatric patients who were studied prior 
to commencing lithium therapy, the uptake of Li+ was similar to that of the control 
group. This is contrary to the studies which report an altered Na+-Li+ countertransport 
mechanism in affective patients (24).
The data from the control group, for the uptake of Li+ into erythrocytes over the 
first lOh, gives a l^t order rate constant of 4.93 x lQ-3 min-1 (correlation coefficient of 
0.977), and a corresponding half-life of 2.3h. This is faster than that of a similar 
experiment in which a rate constant of 3.33 x lO'^ min-  ^ for the uptake of Li+ was 
reported {3), The difference may be because the reported value was calculated from 
data over a much longer time period than this work (33h compared to lOh), or may be 
due to differences in the experimental conditions. Perhaps more importantly the 
reported value was the result of only a single experiment, compared to the averaged 
data for twelve such experiments in this work.
The results for the male control on commencing lithium treatment clearly show a 
Li+-induced change in the uptake of Li+ which occurred after 3 weeks treatment (Figure 
3.5A). Thus it may be that treatment with Li+ is also responsible for the altered Li+ 
uptake behaviour observed in the patients stabilised on lithium compared to the controls
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(Figure 3.4). This is consistent with the Li+-induced inhibition of the Na+-Li+ 
countertransport previously reported {23). A similar Li+-induced effect on the uptake 
of Li+ into erythrocytes was observed after 2 weeks Li+ treatment for patient AR 
(Figure 3.6A), and after only a few days treatment for patients MP, CT and JD 
(Figures 3.7A, C and 3.6B, respectively). However, in the latter case, this cannot be 
confirmed since no pre-treatment experiment was performed. The different time delays 
before an effect was obtained may be related to the observed variability in the time 
periods before a clinical effect of Li+ occurs in patients, or alternatively may be related 
to the psychotic state of the patients on commencing therapy.
The absence of an effect in the female control after 4 weeks Li+ treatment 
(Figure 3.5B) and in one of the patients after 6 weeks therapy (Figure 3.7B) may be 
due to other medical factors, such as the illness suffered by the control, or to the 
additional medications, or alternatively it may possibly indicate that these people are 
non-responders to Li+ treatment. It is also possible that these people need to take Li+ 
for longer periods before the Li+ uptake behaviour is altered.
In the patients commencing Li+ therapy, there was no control over many factors 
which may have contributed to the inconsistent Li+ uptake results. For instance, the 
time the blood sample was taken relative to the previous administration of Li+ or of 
other medications, or to the time of the previous meal, was not controlled. Also, the 
psychiatric state of the patient at the time of acquiring the sample was not known. An 
extended study, with more control over such factors, and with a larger number of 
patients would be required to determine the origin of these inconsistencies. 
Additionally, similar studies with patients suffering from different psychiatric disorders 
(bipolar, unipolar) or with patients in different psychotic phases (mania, depression, 
normal) could be undertaken. It has been reported that the Li+in /  Li+out ratio and/or the 
activity of the Na+-Li+ countertransport process may be related to the nature of the 
disorder ( i i ,73,74,24), or to the psychotic state of the patient {25).
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At first glance, the absence of any effect of changing the extracellular [K+] upon 
the transport of Li+ might have been predicted. The two passive Li+ influx pathways 
and the Na+-Li+ countertransport mechanism are not directly affected by the [K+]out* 
However, changes in the [K+]out were achieved by corresponding changes in the 
[Na+]out to maintain the osmolarity of the medium. Therefore, the transmembrane Na+ 
and K+ concentration gradients were altered and this might be expected to interfere with 
the Na+-dependent Li+ efflux mechanism. Unfortunately, under the conditions used 
there was no apparent effect on the Li+ transport behaviour.
The linear uptake of Li+ into rat erythrocytes and the higher accumulation of Li+ 
(Figure 3.9A), relative to human erythrocytes, is consistent with the absence of a Na+- 
Li+ countertransport system in the erythrocytes of this mammal (26). However, this 
transport mechanism is present in the erythrocytes of many other mammals, including 
rabbits, and generally the activity of this process is increased relative to that in human 
erythrocytes (26).
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Chapter 4
Lithium NMR Spectroscopy of Cells and Organs
9 3
3
4 ,1  Nmr Spectroscopy of Cells and Organs
In addition to the study of the metabolism of erythrocytes, nmr spectroscopy 
can be applied to similar studies of other intact cells and of perfused organs, and to in 
vivo studies.
4 . 1 . 1  Techniques for Studying Cell Suspensions
The main difficulty associated with the study of cell suspensions is the high cell 
density required to be maintained in the relatively small volume within the detection coil 
of the spectrometer, for adequate signal-to-noise ratio to be obtained without depleting 
the cells of the nutrients and oxygen required to sustain life. Thus the majority of 
research has centred on yeast, bacteria and protozoa which can be successfully grown 
to high density in suspension. However, a number of ingenious techniques has been 
developed to allow continual perfusion of the cells whilst avoiding the problem of the 
cells flowing with the perfusate.
Some tumour-derived cell types and continuous cell lines can be grown as free 
cells in suspension however most cells can only be cultured on solid supports. Free 
cells in suspension tend to flow with the perfusate and block the filters employed to 
restrain them. Two methods have been developed to avoid this problem. First, the 
cells can be embedded within a perfusible gel matrix, for example agarose, which can 
then be drawn out into fine threads and restrained within the nmr tube by a filter, thus 
maintaining the cells in a fixed position and optimizing the flow of nutrients to the cells 
(1). Secondly, the cell suspension can be perfused by the use of a continuous loop of 
fine, hollow-fibre dialysis tubing through which the oxygenated medium can be 
pumped (2). These fibres only occupy a small fraction (approximately 1/6) of the 
sample volume, however this method does require modification of the nmr tube so that 
it is hermetically sealed.
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Alternatively for anchorage-dependent cells, high densities can be achieved by 
growing the cells on solid supports, such as microcarrier beads or fibres, which can be 
easily transferred to a nmr tube and perfused with medium. To minimize detachment of 
the cells from the solid support, the flow rate of the perfusate is kept low. Cells have 
been grown on the outer surfaces of hollow fibres, through which the medium is 
perfused in a similar manner to that used for the free cells in suspension (3,4), on the 
surfaces of microcarrier beads (5,6) and on polyester fibres (6). In the latter two 
methods, nylon mesh screens were employed as filters to restrain the supports in the 
nmr tube. The nmr spectra of human breast cancer cells grown either on 
polyacrolein microcarriers or on polyester fibres were more reproducible than the 
spectra of cells embedded in gel threads, and investigation by scanning electron 
micrographs revealed differences in the assembly and shape of the cells cultured by the 
three methods (6). Not surprisingly, the cells grown on the beads and the fibres 
retained the shape and appearance of cells grown regularly in a monolayer, whilst those 
embedded in the gel were dispersed and spherical, lacking the surface filaments that 
provide contact between cells. The main disadvantage of these solid supports is the 
significant proportion of the sample volume they occupy; a value of 65% is reported in 
an experiment using microcarrier beads of 160-300|J,m diameter (7).
4.1.2 2^Na-, and '^Li-Nmr Spectroscopy of Cells and Organisms
Nmr spectroscopy has been applied by a number of groups to the study of 
intracellular Na+, but to date is very limited with respect to intracellular Li+. Using 
methods similar to those used for suspensions of erythrocytes, 23Na-nmr spectroscopy 
has been applied to the study of human lymphocytes (5), rat cardiac myocytes (9), 
amphibian oocytes (10), rat kidney tubules (11), frog sartorius muscle (12) and rat 
abdominal muscle (13). In all these systems, the cells and tissues were suspended in
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an isotonic medium containing a shift reagent, usually Dy(P3 0 io)2 "^> and were not 
perfused.
In one ^^Na study of a suspension of Na+-rich yeast cells, using Dy(NTA)2^ ', 
to separate the intra-, and the extracellular 23Na resonances, the efflux of Na+ from the 
cells was monitored with respect to time (14), The cells were free in suspension and 
were not perfused, however occasional gentle pipetting prevented the cells settling. 
This study also demonstrated the potential of ^ Li-nmr for the study of intracellular Li+ 
using the same shift reagent. Similarly, ^Li-nmr has been used to study the Li+ content 
of, and the transport of Li+ into a suspension of rat hepatocytes using the shift reagent 
Dy(P30io)2^" (15). The initial uptake of Li+ into the hepatocytes was rapid and 
saturation of the intracellular Li+ occurred within Ih. As observed with erythrocytes, 
the [Li+]in at saturation was low compared to the [Li+]out " the ratio [Li+]in /  [Li+Jout 
was approximately 0.04, 0.06 and 0.07 at [Li+]out of 8.3, 10.2 and 12.5mM, 
indicating the presence of a transport mechanism to maintain this low [Li+]in. It should 
be noted that this study used a very short interpulse delay (3s) which is probably 
insufficient for complete magnetic relaxation all the Li+ species present, even though 
the applied pulse was only 45% and therefore the absolute values for the [Li+] should 
be treated with caution.
The applicability of the methods described above for nmr studies of intact, 
anchorage-dependent cells was demonstrated in a ^IP- and ^^Na-nmr study of resting 
and stimulated mast cells (7). The cells were grown as a monolayer on microcarrier 
beads and perfused with an oxygenated medium. The intra-, and extracellular Na+ 
resonances were distinguished using a Hepes buffer containing Dy(P30io)2^‘. and the 
viability of the cells was determined by monitoring the phosphorous metabolites using 
31p nmr spectroscopy.
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4 .2  Nmr Spectroscopy and Imaging of Organs
Cells, small tissue samples and small organs can be studied in suspension in 
standard, or sometimes modified, nmr tubes placed within the existing RF coils of the 
spectrometer. However, for the study of larger organs and whole bodies, magnetic 
resonance spectroscopy (MRS) employing specially adapted surface coils or magnetic 
resonance imaging (MRI) in which the whole body or organ is surrounded by the 
detection coil can be employed. Both methods have been extensively developed and 
produce excellent resolution for in vivo studies, with minimal risk to the subject (animal 
or human).
For MRS, the surface coil is placed on the surface of the individual adjacent to 
the organ or tissue of interest or, for longer term studies, the coil can be surgically 
implanted in the animal. The intensity of the RF field decreases with distance from the 
plane of a surface coil and the sampling volume is roughly hemispheric. A 
considerable amount of work has gone into coil design to achieve optimum coverage of 
the surface of interest. Thus a surface coil placed over the head, for example, will 
detect signals fi*om nuclei in overlying muscle and bone as well as from the brain.
Localisation techniques, which are really extensions of MRI techniques, can be 
employed with MRS to investigate defined volumes, for example the various anatomic 
regions within the brain. By applying magnetic field gradients across the volume of 
interest, the frequency of the signal becomes a function of the distance from the coil, 
thus providing spatial resolution of the signal. In MRI, magnetic field gradients are 
superimposed in 3 orthogonal directions on the organ or body of interest. The field 
gradients are varied in 2 of these directions such that the frequency becomes a function 
of the position, producing spatial resolution. MRI can image in all planes and can 
therefore produce a 3 dimensional reconstruction of a particular nucleus within an 
organ.
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4.2.1  23Na-, and ^Li-Nmr Spectroscopy of Perfused Organs
The continuous measurement of tissue contents of electrolytes (Na+, Li+ and 
Cl") in intact ex vivo organs by nmr spectroscopy was demonstrated by a study on the 
perfused salivary gland from a rat, suspended inside a 10mm nmr tube (16). No shift 
reagent was employed in this study and therefore a single resonance was observed for 
each of the ions. The kinetics for both the decrease in the intensity of the Na+ signal 
and the increase in that of the Li+ signal, were followed with time when Li+ was 
substituted for Na+ in the perfusate.
The study of intracellular Na+, K+ and Li+ in a perfused organ, by nmr 
spectroscopy, was demonstrated by cannulating the venous input and allowing the 
perfusate to mimic the normal blood flow through the excised heart of a frog (17). The 
heart and cannular apparatus were placed in a 20mm nmr tube with the heart being 
completely submerged in the perfusate. Using Dy(?30io)2^" (3.0mM) to separate the 
intra-, and the extracellular resonances, chemical shifts of approximately 6.5ppm for 
Na+, 3.5ppm for K+, and 3.2ppm for Li+ (perfusate containing 80mMLi+) were 
obtained. The Ti and T2 relaxation times for the intracellular Li+ were 700 and 31ms, 
respectively.
4 .2 .2  In  VÏVO 23]Va-Nmr Spectroscopy
The use of in vivo and 31p nmr-spectroscopy and nmr-imaging is now 
widespread and certain other nuclei, such as 23Na, 13c and are being
investigated. The potential use of shift reagents in vivo has been demonstrated by 
^^Na-nmr spectroscopy. Dy(TTHA)3- was continuously infused into the bloodstream 
of a gerbil by introduction into the femoral vein to distinguish between the intra-, and 
the extracellular ^ ^Na resonances in vivo in both the brain and the leg muscle (18). In 
the spectra of the leg muscle, the two expected signals were observed however, in the
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spectra of the brain, 3 signals were observed and were assigned to the intracellular 
Na+, the extracellular-extravascular Na+, and the intravascular Na+. The appearance of 
the signal from the extravascular-extracellular Na+ indicates the permeability of the 
blood-brain barrier to the shift reagent and demonstrates a further potential application 
of this technique. Once again, 3 Ip nmr spectroscopy was employed to monitor 
changes in either the phosphorous metabolites or in the intracellular pH.
4 .2 .3  In Vivo ^Li-Nmr Spectroscopy and Imaging
To date, very few studies of in vivo ^Li-nmr spectroscopy and imaging have 
been reported. ^Li-nmr imaging is an ideal method to monitor the Li+ distribution non- 
invasively in the human brain. It has the potential to lead to insights in the locus of 
action of Li+ in psychiatric therapy and, for instance, differences in the distribution of 
Li+ in the brain may be related to differences in the clinical response or the efficacy of 
the drug.
Using surface coils, in vivo ^Li-nmr spectroscopy has been applied to humans, 
following the oral administration of Li2C03. By the careful use of Li+ standards made 
from agarose phantoms, quantification of the [Li+] in the brain and in the calf muscle 
has been performed and compared with that in the serum. Following ingestion of a 
single dose of the drug by a healthy individual, the Li+ level in the serum increased 
rapidly and peaked after approximately 4h, whereas the levels in the muscle and the 
brain rose more slowly and were still increasing after 8h (19). The Ti of Li+ in the 
muscle was 7s. Monitoring of the [Li+] during several days of treatment, showed that 
the accumulation of Li+ in the serum was more rapid and to a higher level than that in 
the muscle, which was in turn more rapid and to a higher level than that in the brain. 
When the treatment was stopped, Li+ was eliminated rapidly from both the serum and 
the muscle, whereas the level in the brain decreased very slowly (19,20). Similar data 
was reported for a patient suffering from bipolar affective disorder commencing Li+
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therapy, however in this case the level in the brain rose more rapidly than that in the 
muscle (20). A patient suffering from schizoaffective disorder, who had been taking 
Li+ for 6 months, was monitored by ^Li-nmr for several months over which time the 
[Li+] in the brain fluctuated over the range 0.45 - 0.84mM (20). The reason behind the 
fluctuating levels is not understood, however the brain [Li+] did correlate with that in 
the serum. Similarly, in two studies of a number of patients suffering from bipolar 
affective disorder and stabilised on Li+ therapy, the levels in the brain and the muscle 
were consistently lower than that in the serum, and there was a positive correlation 
between the serum [Li+] and the brain [Li+] (21,22). In one particular individual it was 
noted that, although the brain [Li+] was lower than the serum [Li+] during both the 
depression and the mania, during the switch from the depressive to the manic episode, 
the level in the brain exceed that in the serum (22). A  Tj of 3.4 ± 0.5s for Li+ in the 
brain of patients suffering bipolar disorder was reported (23).
In vivo ^Li-nmr spectroscopy has also been applied to the study of 
anaesthetized rats following injection with LiCl, when a dose dependent increase in the 
intensity of the ^Li signals in the brain was reported (24,25). Following a single dose 
of LiCl, in the range 2-lOmmol.kg-l, the [Li+] in the brain reached a maximum after 
approximately 8h and then decreased to only half its value in approximately 20h (25). 
Localised spectroscopy, of 0.5ml sample volumes from the front, centre and rear of the 
brain, suggested that the Li+ was uniformly distributed. This technique also showed 
that there was no reduction in the signal intensity even 20h after administration of the 
LiCl, suggesting that the decrease observed by non-localised spectroscopy may be due 
to elimination of Li+ from the extracranial tissue (25). The T% for Li+ in the rat brain 
was 4.1s.
The first ^Li-nmr image of a body section was of the upper abdomen of a rat, 
which had been administered 2 doses of LiCl i.p. (10mmol.kg'l), with a 24h interval 
between doses, prior to sacrificing (26). The image, recorded over 4h with a resolution 
of 5mm, showed a higher [Li+] in both the perivertebral muscle and the liver, relative to
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that in the stomach. Two T2 values, of 10ms and 100ms, were determined; the 
biphasic behaviour being ascribed to weak macromolecular binding of Li+. The same 
group then applied '^Li-nmr imaging to the head of an anaesthetized puppy, following 
administration of i.p. injections of LiCl (27). The low resolution of the resulting 
image, recorded over 4h, did not allow any anatomical features to be distinguished. 
Both Ti and T2 showed biexponential behaviour, which was again ascribed to a rapid 
exchange between free and bound Li+. However, the 2 different relaxation times may 
simply be due to Li+ species in different pools, for example in the intracellular fluid, in 
the CSF, in the blood or in extracranial tissue.
A recently reported Li-nmr image of a rat head shows a significant improvement 
in definition, where the brain stem and the spinal cord region can be distinguished (25). 
The most intense signal is from the muscle in the neck behind and below the brain, 
which is approximately twice that in the brain. The tongue also shows substantial 
signal intensity. Within the brain region itself, the [Li+] is relatively uniform, with the 
level in the cerebellum approximately 30% lower than that in the front of the brain.
The reports described above illustrate the wide potential for both ^Li-nmr 
spectroscopy and ^Li-nmr imaging in vivo in psychiatric research. Applying a method 
modified from that used for ^^Na-nmr spectroscopy of mast cells (7), the following 
section reports an original investigation into the potential of employing ^Li-nmr 
spectroscopy to study intracellular Li+ in human brain cells, using a cell line derived 
from a brain tumour. The use of shift reagents in vivo has also been investigated in 
order to study Li+ in the various environments within rat brain.
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4 .3  and ^^Na-Nmr Spectroscopy of Human 1321 NI
Astrocytomas
Human 1321 N1 astrocytomas, a cell line derived from a brain tumour, were 
cultured on the surface of microcarrier beads (250pm diameter) to facilitate the nmr 
experiment. This produced a density of approximately 4x  10  ^cells (80mg protein) per 
ml of beads packed under gravity (28). ^Li-, and ^^Na-nmr spectra were recorded after 
resuspending the beads/cells in a buffer containing Dy(P3 0 io)2^“ to distinguish the 
intra-, and extracellular resonances for both cations. Typical spectra, illustrating the 
excellent resolution achieved for both ^Li and 23Na, are shown in Figures 4.1 and 4.2, 
respectively. In both figures, the lower trace is simply an expansion of the upper trace. 
In the ^Li spectrum, the shift difference is 4.3ppm and the CO 1/2 are 80 and 33Hz for 
the signals from the Li+in and Li+out, respectively. In the 23Na spectrum, the chemical 
shift difference is 6.74ppm and the (O1/2 are 98 and 78Hz for the signals from the 
Na+in and Na+out, respectively. 31p nmr spectroscopy was employed to monitor the 
viability of the cells throughout the experiment (see Section 2.2.1).
4 .3 .1  Astrocytomas Preloaded with Li+
A sample of astrocytomas was preloaded with Li+ by including LiCl (16.6mM) 
in the culture medium for 24h prior to the nmr experiment. This ensured that sufficient 
Li+ was present inside the cells to be easily observed by ^Li-nmr spectroscopy. The 
nmr spectra were recorded after resuspending the beads/cells in a buffer containing 
Dy(P30io)2^“ (3mM) and LiCl (lOmM). In the ^Li spectrum, the integral of the 
intracellular signal (lin) was approximately 6.1% that of the extracellular signal (lout) 
and in the ^^Na spectrum, the lin was approximately 2.4% of the lout- This latter value 
compares with lin of 2.5% of lout reported for the 23Na-nmr spectrum of mast cells, 
cultured on the same beads, in a similar buffer not containing Li+ (7). Analysis of both 
the 23Na-, and the ^Li-nmr spectra of both the suspension of beads/cells and the
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Figure 4.1 ^Li-nmr spectra of astrocytomas on microcarrier beads, in a buffer
containing Dy(p30io)2^ “
(Each spectrum is the sum of 48 acquisitions recorded at 194MHz, [Li+]out = lOmM)
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Figure 4.2 ^^Na-nmr spectra of astrocytomas on microcarrier beads, in a buffer
containing Dy(P30io)2^ "
(Each spectrum is the sum of 1200 acquisitions recorded at 132MHz,
[Na+]out = 90mM)
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corresponding buffer, established that the microcarrier beads occupied approximately 
50%, and the intracellular volume was approximately 8.5%, of the total sample volume 
(see Section 2.2.3). This compares with the reported values of 65% occupied by beads 
and 4% by the mast cells (7). Assuming the [Na+]in was 20mM, the [Li+]jn was 
calculated to be approximately 3.1mM, giving the ratio [Li+]in /  [Li+]out of 
approximately 0.3.
4 .3 .2  Uptake of Li+ into Astrocytomas
The uptake of Li+ into the astrocytomas was monitored with respect to time by 
^Li-nmr. The cells were incubated at 37“C in a buffer containing either lOmM Li+, 
when data was acquired for 25min. per spectrum, or 50mM Li+, when data was 
acquired for 4min. per spectrum. The higher concentration improved the time 
resolution for the initial uptake of Li+ by achieving adequate signal-to-noise with fewer 
scans. From both the ^^Na and the ^Li nmr data, the volume occupied by the beads 
was approximately 30%, the lower value probably being due to the modified procedure 
of filling the the nmr tube with buffer to prolong the life of the cells (see Section 2.2.2), 
and the intracellular volume was approximately 6.7%,
Figure 4.3 shows the time dependence of the integral of the Li+in resonance as a 
percentage of that of the Li+out resonance, at both concentrations of Li+out- lOmM 
Li+out» it can be seen that the initial uptake of Li+ is rapid and that saturation occurs 
within 60min., when the lin is approximately 9% of the lout- This corresponds to a 
[Li+]in of approximately 4.5mM, and thus the ratio [Li+]in /  [Li+]out is approximately 
0.45. At 50mM Li+out, the lin is approximately 3% of lout after 30min. which 
corresponds to [Li+]in of approximately 16mM and thus a ratio of [Li+]in /  [Li+]out of 
approximately 0.32. The graphs show that the uptake appears to follow 1st order 
kinetics and a rate constant of 5.5 x 10"^  ± 0.75 x lO’^  min.-l has been determined for a
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Figure 4.3 The time dependence of the integral of the intracellular Li+ 
resonance, I(Li+in), as a percentage of that of the extracellular resonance, I(Li+out)» in 
astrocytomas at (A) lOmM and (B) 50mM Li+o^j
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[Li+]outof 50mM. This corresponds to a half-life of approximately 12,6min..
4 .4  In Vivo Li-Nmr Spectroscopy of Rat Brain
In vivo ^Li-nmr spectra of the head of anaesthetised rats, pretreated with LiCl, 
were obtained by using a surface coil placed on the scalp. Contrast reagents were 
injected into the bloodstream of the rats via the tail vein, in order to distinguish the 
various Li+ pools within the brain. High quality ^Li spectra were obtained within 
15min. of administering the LiCl to the rats, i.e. as soon as the animal could be 
positioned in the magnet after dosing. Li+ doses of 1-lOmmol.kg-l, and contrast 
reagent doses of 0.5-2.0mmol.kg"l, were administered.
All the spectra obtained showed only a single ^Li resonance, with (Oi/2's in the 
range 30-80Hz, depending on the homogeneity of the field. No separation of the 
resonances from Li+ in different environments was achieved with any of the shift 
reagents, even in the spectra from the rats treated with several doses of Li+ for up to 2 
days prior to the experiment. No significant changes in either the CO 1/2 or the integral 
of the resonance was observed, and in general, the chemical shift of the resonance did 
not change significantly with any of the reagents employed. In only one experiment 
was a significant shift difference of 2.76ppm obtained, and as can be seen in Figure 
4.4, even this did not show any separation of resonances from the different Li+ pools. 
Although quantification was not possible under the conditions used, increasing the dose 
administered from 1 or 2mmol.kg l, to lOmmol.kg-l, did not appear to increase the 
intensity of the signal, indicating that the signal was probably saturated.
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Figure 4.4 In vivo ^Li-nmr spectra of the head of an anaesthetised rat after 
administration of: (A) LiCl (10.8mmol.kg-l), Dy(TTHA)3- (1.8mmol.kg"^) and 
GdNOs (2ramol.kg“l); and (B) LiCl (7.2mmol.kg“l) and Dy(TTHA)3- (1.2mmol.kg'l)
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4.5  Discussion
The results obtained with the astrocytomas demonstrates the potential for the 
non-invasive nmr study of intracellular Li+ in excitable cells. Although absolute values 
for the intracellular concentrations were not obtained in this study, the data suggests 
that the intracellular [Li+] is low with respect to the extracellular concentration, as in 
erythrocytes. This is in agreement with data obtained by AAS on primary nerve cells 
from chick embryos (29,30) and on cultured mouse neuroblastoma x glial hybrids (31), 
but it is in contrast to the data from cultured rat glioma cells (32) and mouse 
neuroblastoma cells (33), which reported that, even in the resting state, these cells 
accumulate Li+ against the chemical gradient. Obviously, these differences may be due 
to the two experimental techniques employed, but are more likely to be due to the 
different cell lines or the different species studied, and illustrates the danger of 
extrapolating such data to human brain cells. The relatively low intracellular [Li+] in 
the astrocytomas indicates the presence of a mechanism for transporting Li+ out of the 
cells against its concentration gradient, possibly a Na+-Li+ countertransport system 
similar to that found in human erythrocytes. A Na+-Li+ exchange process has been 
reported in primary nerve cells (29) and in mouse neuroblastoma x glial hybrids (34). 
If this Li+ efflux mechanism is absent in rat glioma cells, as is the case in rat 
erythrocytes (35), this may explain the high levels of intracellular Li+ accumulated by 
these cells.
The uptake of Li+ into the astrocytomas is rapid, being approximately 10 times 
faster than that into erythrocytes (Section 3.4). Equilibration is achieved within 60min. 
and this appears to represent the true steady-state for Li+ movement, since the ratio 
[Li+]in /  [Li+]out after 60min. was similar to that obtained after 24h. This rapid initial 
uptake followed by saturation is typical of the behaviour of Li+ uptake in the other brain 
cells studied by AAS (29,31,32,33,36) and illustrates how the Li+ transport behaviour 
in brain cells differs from that in erythrocytes. Indeed, the movement of Li+ though the
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voltage-dependent Na+ channel has previously been demonstrated in nerve cells 
(31,34). This transporter is absent in electrically passive tissue, such as erythrocytes.
Li+ transport processes and intracellular concentrations in the brain can be 
approached by using nerve cell culture as a intact model system. Obviously, the study 
of human nerve cells is likely to be more relevant to the study of the mechanism of 
action of Li+ in psychiatric therapy, than either the study of human erythrocytes or the 
study of nerve cells from other mammalian species. However, it should be 
remembered that different behaviour between cells from immortalized cell lines and 
those present in normal mammalian brain may also be significant.
This preliminary study illustrates the potential for ^ Li-nmr spectroscopy in this 
field of research. Once the relaxation times and nmr-visibility of the cations have been 
established, detailed quantitative analysis of intracellular [Li+] and transport behaviour 
can be studied at physiological [Li+] in any in vitro cell system.
Although the object of the in vivo work, to observe intracellular Li+ in rat 
brain, was not achieved, the potential for this method remains. It appears likely that, 
under the conditions of the experiment, the shift reagents were not entering the 
bloodstream and were, therefore, not reaching the brain, or that the shift reagent was 
not able to cross the blood brain barrier. It may be that continuous infusion of the shift 
reagent into the animal is required to attain and maintain the necessary concentration in 
the brain. It is also likely that the repetition rate employed (2s) was too short to give 
acceptable signal to noise for the intracellular Li+ resonance, even if the extracellular 
signal had been shifted - a Tj of 4.1s for total Li+ in rat brain in the absence of a shift 
reagent, has been reported (25), Given that the ^^Na signals have been reported to be 
distinguished in vivo in the various compartments within the gerbil brain using 
continuous infusion of Dy(TTHA)3- (18), and that Li+ signals have been distinguished 
ex vivo, in perfused organs using chemical shift reagents (16,17), there is no apparent 
reason why intracellular Li+ may not be observed in vivo, under the right conditions. It
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may be that the blood brain barrier in rats is impermeable to the shift reagents 
employed, a problem apparently not experienced in the study with the gerbil. The 
toxicity of these reagents means their use in human studies in vivo is unlikely, although 
their applicability to animal studies remains a valuable asset.
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Chapter 5
Effect of Lithium upon the Composition of the 
Erythrocyte Membrane
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5 .1  Effect of Li+ upon Erythrocyte Membrane Processes
Several specific transport processes in erythrocytes are altered after the initiation 
of Li+ treatment, including the Na+/K+ pump, the Ca^+ pump, choline transport and 
the Na+-Li+ countertransport. The inhibition of this latter process is most likely 
responsible for the altered Li+ transport behaviour observed in this work, in Chapter 3. 
Any of these changes could be important in the therapeutic action of Li+ and/or may be 
the underlying molecular basis of bipolar affective disorder. Alternatively, these 
abnormalities may be the consequence of a more general defect in membrane 
composition and structure, and it has been suggested that a membrane defect could be 
indicative of a predisposition to the affective disorders.
Membrane lipids serve as the molecular cement for membranes and regulate the 
lateral movement of membrane-proteins. Changes in lipid composition would be 
expected to result in changes in forces between membrane components, such as 
receptors and transport systems. For instance, changing the relative amounts of acidic 
and neutral lipids would alter the charge density and could result in a dramatic change in 
membrane binding. It has been shown that the activity of the enzyme Na+/K+ ATPase 
is significantly dependent on the membrane lipid content (1). Since the transport of 
neurotransmitters and their precursors occurs at the membrane, and the receptor 
complexes are located on the membrane surface, it is not unreasonable to suggest that 
membrane defects are likely to have significant effects on neurotransmitter availability 
and the transduction of receptor-mediated signals.
Li+ inhibits myo-inositol monophosphatase, the enzyme responsible for the 
formation of myo-inositol from inositol-1-phosphate, I(l)Pi, thus leading to a decline 
in the levels of myo-inositol. Both choline and myo-inositol are precursors for the 
synthesis of membrane phospholipids: choline for phosphatidylcholine (PC) and 
sphingomyelin (Sph), and myo-inositol for phosphatidylinositol (PI) and the 
polyphosphoinositides. Therefore, since Li+ alters the metabolism of both these
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precursors, it is possible that Li+ is involved in altering the composition of the tissue 
phospholipids.
5 .1 .1  Effect of Li+ upon the ATPases
Erythrocyte membrane abnormalities in bipolar disorder were first observed in 
studies of the enzyme Na+/K+-ATPase. A Li+-induced increase in the activity of the 
Na+/K+-ATPase was observed in the erythrocytes of Li+-treated bipolar and unipolar 
patients (2,5), and the concentration of the enzyme Ca^+-ATPase was found to be 
increased in the erythrocyte membranes of Li+-treated bipolar patients compared to 
those of controls (4).
5 .1 .2  Effect of Li+ upon Choline Transport
Choline transport across the erythrocyte membrane is irreversibly reduced by 
90% as a consequence of chronic Li+ treatment (5). In the erythrocytes of Li+-treated 
patients, significant accumulation of intracellular choline occurs despite unchanged 
levels of endogenous choline in plasma (6,7). The affinity of the transport system for 
choline was found to be unchanged by Li+ treatment whereas the Vmax was reduced 
3-fold, implying that either the number of transporting molecules had been reduced or 
that the ability of the choline-carrier complex to cross membrane was impaired (S) . 
This implied that an irreversible change in the composition of the membrane had 
occurred, either as a result of a change in the amount of specific constituents or a 
conformational change in the complex. Following chronic treatment with Li+, 
increased uptake of choline into the brain and stimulation of the conversion of choline 
into the neurotransmitter acetylcholine in rats has been reported (9). Hence, the 
beneficial effect of Li+ may be due to an increase in the availability of acetylcholine in 
response to lithium therapy.
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5 .1 .3  Na+-Li+ Countertransport and Membrane Composition
The molecular structure of the carrier in the erythrocyte membrane which is 
responsible for the Na+-Li+ countertransport has not yet been elucidated, however it is 
known that the carrier is significantly influenced by the lipid components of the 
membrane. Therefore, a deficiency in the Na+-Li+ countertransport system may be 
associated with abnormalities in membrane lipid composition. There is evidence that 
the Na+-Li+ countertransport activity is altered by changes in the concentrations of 
plasma lipids and, since the erythrocyte membrane lipids are in a dynamic equilibrium 
with the plasma lipids, any change in the levels of the plasma lipids may alter the 
composition of the erythrocyte membrane (10). In hypertensive patients, the activity of 
the Na+-Li+ countertransport in erythrocytes was found to correlate positively with total 
cholesterol and triglycerides, and negatively with high density lipoprotein (HDL) 
cholesterol (11). The activity was also found to correlate positively with the saturated, 
and to correlate negatively with the unsaturated fatty acids of erythrocyte lipids of 
normotensive subjects (12,13). In patients suffering bipolar affective disorder, a 
negative association between the activity of Na+-Li+ countertransport in erythrocytes 
and HDL cholesterol has been reported (14).
In erythrocytes, the Na+-Li+ countertransport activity is reduced in vitro by 
increases in the level of cholesterol (15), and is considerably altered by subtle changes 
in the fatty acid composition of PC, induced by the in vitro replacement of some of the 
native PC (15,16).
5 .1 .4  Erythrocyte Lipids in Li+-Treated Psychiatric Patients
There is some evidence that abnormalities exist in the erythrocyte membranes of 
patients suffering psychiatric illnesses. Studies of the lipid content of the membranes 
of erythrocyte ghosts from Li+-treated patients suffering various forms of
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schizophrenia reported that, compared to healthy Li+-treated controls, the membranes 
of the patients had a significantly lower levels of PC, and this was accompanied by 
increased levels of phosphatidylethanolamine (PE) and Sph (77), by increased levels of 
phosphatidylserine (PS) (75), or by increased levels of PS and decreased levels of PE 
(19,20). Schizophrenic patients also appeared to have different levels of 
sphingomyelin fatty acids than the controls (77). However, no differences were 
observed in the cholesterol/phospholipid ratio, a primary factor in determining 
membrane fluidity (77). The membrane composition of manic patients was found to be 
similar to the controls (79).
These changes in the relative concentrations of the various phospholipids can be 
rationalised by considering the normal enzymatic biosynthesis of PC in membranes 
which involves the decarboxylation of PS followed by successive N-methylations of 
PE (27):
CH3 CH3
PS V. PE PE PCmono methyl
CO2
Therefore, inhibition of the decarboxylation step would lead to a build up of PS at the 
expense of PE and PC. Similarly, inhibition of the méthylation steps would lead to a 
build up of PE at the expense of PC. Interestingly, neuroleptic drugs are known to 
block the méthylation reactions and hence, it has been suggested that a decrease in PE 
may play a role in psychotic symptoms (20).
5 .1 .5  Effect of Li+ upon Cortical Phospholipids in Rat
Acute treatment of Li+, using relatively high doses (9 or 12mmol.kg'l), 
produced a significant decrease in the level of PE and an increase in the relative level of
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sph in rat cerebral cortex (22). Chronic dietary administration of Li+ produced a 
significant decrease in PI and PE with an increase in PC. Interestingly, a decrease in PI 
is postulated from the inhibition of inositol monophosphatase. The decrease in PE 
accompanied by an increase in PC, and in Sph following acute treatment, may again 
reflect changes in the choline metabolism since choline is a precursor for both of these. 
PE is converted to PC by N-methylation, and subsequently to choline (21).
5 . 1 . 6  Effect of Li+ upon Membrane Proteins
A difference in the concentration of a minor membrane-associated protein has 
been observed in the erythrocytes of Li+-treated patients. The spectrin-actin 
cytoskeleton of erythrocytes is linked to some of the integral membrane proteins by 
ankyrins. The major ankyrin in human erythrocytes is ankyrin 2.1, however higher 
than normal levels of ankyrin 2.3 have been reported in patients suffering from bipolar 
affective disorder, both before and during Li+ therapy (23,24).
5 .2  Li+ Treatment and Erythrocyte Membrane Composition
The abnormal transport behaviour observed on the initiation of Li+ therapy 
observed in this work, in Chapter 3, may be the consequence of a Li+~induced change 
in the composition of the erythrocyte membrane. The human erythrocyte membrane is 
primarily composed of protein (approximately 50%) and lipid (approximately 44%). 
Therefore, to investigate the effect of Li+ treatment on the composition of this 
membrane, the erythrocytes of Li+-free healthy controls and of Li+-tieated patients 
were analysed for membrane lipid content by high performance thin-layer 
chromatography (HP-TLC), and for membrane protein content by gel electrophoresis. 
Comparisons were made to investigate any differences between the 2 groups of 
individuals to account for this observed Li+ transport behaviour.
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5 . 2 , 1  Effect of Li+ Therapy upon the Lipid Content of Human
Erythrocyte Membranes
The lipids were extracted from the erythrocyte membranes of both Li+-free 
healthy controls and from Li+-treated patients. The lipids were then separated by HP- 
TLC, using the a 2-solvent system which produced a complete separation of the 
phospholipids and cholesterol. The lipids were revealed after charring with a copper 
acetate spray reagent, identified using authentic samples and were quantified by 
densitometric analysis (25).
A  typical chromatogram of the erythrocyte lipids fi'om 3 patients and 3 controls 
is shown in Figure 5.1, and the corresponding Rf values are shown in Table 5.1. As 
can be seen the neutral lipids from human erythrocytes consist almost exclusively of 
cholesterol, in comparison to the standard lipid mixture derived from cod roe, which 
contains substantial amounts of cholesterol esters (CE), triacylglycerol (TAG) and free 
fatty acids (FFA). The phospholipids detected are Sph, PC, PS, PI and PE and, in 
contrast to the erythrocyte membranes, the standard sample contains no PS and a 
significant amount of PI.
Table 5.2 compares the cholesterol and phospholipid content of the erythrocyte 
membranes from Li+-free healthy controls and Li+-treated patients. The data indicates 
that the proportion of cholesterol present appears to be slightly increased in the patient 
group, however this difference is not statistically significant (i.e. below the 95% 
confidence limits).
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Figure 5.1 TLC of human erythrocyte membrane lipids from 3 controls (1-6) and 
3 Li+-treated patients (7-12) in duplicate, developed in solvent systems:(A) chloroform-f-propanol-methyl acetate-methanol-0.25% w/v KCl (25:25:25:10:9); (B) hexane-diethyl ether-acetic acid (80:10:2).
Abbreviations: O-origin; S-standard (cod roe); CE-cholesterol esters; TAG-triacylglycCTol; 
FFA-ffee fatty acids; CH-cholesterol; PE-phosphatidylethanolamine; Pl-phosphatidylinositol; 
PS-phosphatidylserine; PC phosphatidylcholine; Sph-sphingomyelin
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Table 5.1 Rf values of human erythrocyte lipids on TLC in the solvent systems: 
(A) chloroform - f-propanol - methyl acetate - methanol - 0.25% w/v KCl (25 : 25 : 25 
10 :9) and (B) hexane - diethyl ether - acetic acid (8 0 :10: 2).
LIPID COMPONENT Rf
Sphingomyelin 0.05
Phosphatidylcholine 0.09
Phosphatidylinositol 0.16
Phosphatidylethanolamine 0.24
Cholesterol 0.54
Table 5.2 Comparison of the cholesterol (unesterified) and phospholipid content 
of human erythrocyte membranes as a percentage of the total, from Li+-free controls
Phospholipid (PL) Cholesterol (Ch) PL /  Ch
Controls (n=6) 
Patients (n=6)
55.50 ±4.0 44.50 ± 4.0 1.2 
63.29 ±4.1 36.71 ±4.1 1.7
Both Table 5.2 and 5.3 show that there is a significant amount of variation in 
the results obtained and this was found even in the duplicates of the same sample, 
indicating that this behaviour is primarily due to the experimental procedure.
There is also considerable variation reported in the literature for the 
concentrations of the individual phospholipids in erythrocyte membranes, depending 
upon the methods employed. However, Table 5.3 indicates that the results obtained in 
this work using HP-TLC are comparable to levels quoted by Nelson, which are the 
mean values from a number of different studies chosen from the literature (26). In 
general, there is very little difference in the phospholipid content between the Li+-free
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and Li+-treated groups. The level of Sph appears to be very slightly decreased (11%) 
and that of PS is increased (21%) in the Li+-treated group, however these differences 
are not statistically significant. The levels in the control group are consistently closer to 
those of the literature data for 'normal' human erythrocytes, implying that the 
deviations observed in the patient group are probably reliable. Figure 5.2 illustrates the 
phospholipid composition of the erythrocyte membranes for the two groups.
Table 5.3 Comparison of phospholipid content of human erythrocyte membranes.
Phospholipid Controls (n=6) Patients (n=6) Reference (26)
Sph 24.5 ± 1.8 21.9± 1.7 25.8 ± 2.2
PC 29.6 ± 3.2 28.8 ± 2.5 32.2 ± 2.8
PS 14.4 ± 1.8 17.4 ± 1.8 13.0 ±3.1
PI 3.3 ± 2.2 3.2 ± 1.6 1.8 ± 0.8
PE 28.0 ± 2.1 28.4 ± 1.5 27.2 ± 3.0
%
30-
Controls
Patients
Figure 5.2 Comparison of the phospholipid content of erythrocyte membranes, as a 
percentage of the total phospholipids, from Li+-treated psychiatric patients and Li+-free
controls
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5. 2. 2 Lipid Content of Rabbit Erythrocyte Membranes
For comparative purposes, the lipid content of rabbit erythrocytes was also 
determined by HP-TLC. The proportion of cholesterol (56.6 ± 3.9 %) was higher than 
that in humans, giving a lower PL/C ratio of 0.8. Table 5.4 shows that there are a 
couple of significant differences in the proportions of the individual phospholipids 
compared to the human erythrocyte membrane (Table 5.3). There is a decrease in the 
proportion of Sph and a corresponding increase in the proportion of PE, as predicted 
from the literature (26).
Table 5.4 Phospholipid content of rabbit erythrocyte membranes, as a percentage
Phospholipid Rabbits Reference (26)
Sph 13.7 ± 2.6 19.0
PC 29.5 ± 0.1 34.2
PS 16.7 ± 0.7 12.2
PI 2.1 ± 0.8 1,6
PE 38.0 ± 2.7 31.9
5 .2 .3  Effect of Li+ Therapy upon the Protein Content of Human
Erythrocyte Membranes
Erythrocyte ghosts were prepared fi'om the erythrocytes of Li+-free controls and 
of Li+-treated patients, the membrane proteins were solubilised using sodium dodecyl 
sulphate (SDS) and the mixture was fractionated by polyacrylamide gel electrophoresis 
(SDS-PAGE). This produced a size-dependent separation of the membrane proteins 
which were revealed by staining the gel with Coomassie Brilliant Blue.
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Figure 5.3 SDS-PAGE profile of human erythrocyte membrane proteins from 3 controls (2, 6, 8), 3 Li+-treated patients (1, 3, 4) and 2 controls after a 24h in vitro incubation in Li+-containing medium (5,7)
(o = standard mixture of protein molecular weight markers (Biorad Lab. Ltd); the gel was stained with Coomassie Brilliant Blue)
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A photograph of a typical gel of the erythrocyte membrane proteins from 3 
patients and from 3 controls is shown in Figure 5.3. Also included on this gel are the 
proteins from 2 of the controls after a 24h in vitro incubation of the erythrocytes in 
Li+-containing medium. A visual comparison of the chromatograms showed that there 
are no significant differences in the major protein components of the erythrocyte 
membranes of any of these samples. The following general assignments are as 
according to Steck (27) : the very intense band around the 200,000 protein molecular 
weight (m.w.) marker comprises a doublet arising from a - , and p-spectrin; the doublet 
at approximately 78,000 m.w. arises from the Band 4.1 and 4.2 proteins; and the 
intense band at 43,000 m.w. is actin (Band 5). The Band 3 protein, which contains the 
anion channel, occurs as a diffuse zone around the 97650 m.w. marker.
5 .3  Discussion
The main conclusion to draw from this data, using these analytical techniques, 
is that there is very little difference between the concentrations of the major components 
of the erythrocyte membranes of Li+-treated psychiatric patients and of Li+-free healthy 
controls. No significant differences were observed for either the major lipid or the 
major protein content of the erythrocyte membranes. The slightly lower level of Sph 
and corresponding higher level of PS in the Li+-treated patients is not in accordance 
with any of the reported membrane effects of Li+. Interestingly, the levels of PC and 
PE for the 2 groups were virtually identical, in contrast to the data reported for the Li+- 
treated schizophrenic patients (17,18,19,20).
The use of other techniques may be required to identify an abnormality in a 
specific membrane component that was not analysed for in this work. For instance, 
differences in the levels of the fatty acid components of the individual phospholipids 
can be determined by GLC, as observed for Sph from the erythrocytes of the
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schizophrenic patients (17), or alternatively subtle differences in the changes of minor 
protein components can be determined by their isolation and analysis, as in the 
abnormality observed in the ankyrins in bipolar patients (23,24).
Success in identifying a specific membrane fault in bipolar affective disorder 
could lead to a new category of therapeutic drugs to correct for the primary biochemical 
errors in bipolar illnesses, in contrast to present psychopharmacological drugs which 
balance a neurochemical abnormality. Such drugs would regulate either the insertion of 
specific proteins into the membrane, or the mode of linkage of integral membrane 
proteins to the underlying cytoskeleton.
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Chapter 6
Interaction of Lithium with Inositol 
Monophosphatase
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6,1  Li+ and Inositol Monophosphatase
One popular hypothesis for the therapeutic effect of Li+ is its interference with 
inositol lipid metabolism by virtue of its ability to inhibit the enzyme inositol 
1-monophosphatase. Many neurotransmitters act by stimulating the inositol lipid 
metabolism which results in the activation of 2 second messengers: inositol
1,4,5-trisphosphate, Ins(l,4,5)P3, which releases Ca^+ from intracellular stores (1), 
and 1,2-diacylglycerol, 1,2-DG, which activates protein kinase C (2). Thus, it is 
proposed that Li+ alleviates bipolar affective disorder by interfering with the inositol 
phospholipid-dependent intracellular signalling behavioui' of actively stimulated, but not 
resting neurones.
Li+ was first found to interfere with inositol lipid metabolism when decreased 
levels of myo-inositol were observed in the brains of Li+-treated rats (3). Subsequent 
work revealed a corresponding increase in the levels of inositol 1-phosphate, I(l)Pi,
(4), and this behaviour was found to be the result of the inhibition of inositol 1- 
monophosphatase by Li+ (Ki= ImM), the enzyme which converts I(l)Pi to free 
inositol (5).
6 . 1 . 1  The Phosphoinositide Cycle and its Interference by Li+
In the phosphoinositide cycle illustrated in Figure 6.1, the activation of the 
membrane receptor by specific agonists stimulates the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate, PI(4,5)P2, catalysed by the enzyme 
phosphoinositidase C, PIC; a GTP-dependent protein is responsible for coupling the 
activated receptor to PIC (reviewed in reference 6 ). This then generates the 2 second 
messengers, inositol 1,4,5-trisphosphate, I(1,4,5)P3, and sn(l,2)-diacylglyceroI, 
(DAG). PIC also interacts with other inositol phospholipids to give inositol 1,4- 
bisphosphate, I(1,4)P2, and inositol 1-phosphate, I(l)Pi. I(1,4,5)P3 is then recycled
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through two pathways: by dephosphorylation by a 5-phosphatase to produce I(1,4)P2, 
or by phosphorylation catalysed by a 3-kinase to produce inositol 1,3,4,5- 
tetrakisphosphate, I(1,3,4,5)P4, which is thought to be another second messenger. 
Subsequently, I(1,4)P2 and inositol 1,3,4-trisphosphate, 1(1,3,4)P3, the product of 
dephosphorylation of I(1,3,4,5)P4, are both dephosphorylated by inositol 
polyphosphate 1-phosphatase, and all the inositol monophosphate isomers, I(l)Pi, 
I(4)Pi and I(3)Pi, are dephosphorylated by inositol monophosphatase to generate free 
inositol. Both of these latter enzymes, inositol polyphosphate 1-phosphatase and 
inositol monophosphatase, are uncompetitively inhibited by Li+ (5,7j.
uptake
CMP.PA
PI(4)P
\ I(1,4.5>P3
/ X - -
I(3)Pj <------ I(3,4)P2 ^  1(1 ,3,4)P3
synthesis
glucose 6-phosphate
^ I(i,3)P2 recycling 4i(i,3,4,5)r,
Figure 6.1 Scheme of the phosphoinositide recycling pathway, showing the 2 
enzymes which are uncompetitively inhibited by Li+ and the sources of ceUulai* inositol
(i = inositol monophosphatase; 2 = inositol polyphosphate 1-phosphatase)
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PI(4,5)P2, the precursor used by the membrane receptor to generate the second 
messengers, is formed by the phosphorylation of phosphatidylinositol, PI, which, in 
turn, is synthesized from free inositol and cytidine monophosphoryl-phosphatidate, 
CMP.PA, by the action of a synthase, myo-inositol 3-phosphatidyl transferase. 
Therefore, the supply of PI(4,5)P2 available to the receptor, depends upon maintenance 
of the levels of cellular inositol - a reduction in the level of cellular inositol will reduce 
the supply of PI(4,5)P2 and consequently will impair the activation of the receptor in 
response to an agonist and the subsequent formation of the second messengers.
There are 3 sources which contribute to free inositol in cells (illustrated in 
Figure 6.1): de novo synthesis from glucose, in which the penultimate step is the 
cyclisation of glucose-6-phosphate to I(3)Pi, which is then dephosphorylated; from the 
phosphoinositide cycle, whereby the final step is dephosphorylation of the inositol 
monophosphates; and uptake from the extracellular environment. Since Li+ inhibits 
inositol 1-monophosphatase, the enzyme responsible for the dephosphoiylation of the 
inositol monophosphates including l(3)Pi, the first 2 sources of inositol are both 
sensitive to Li+ and, therefore, in the presence of Li+ the extracellular supply of inositol 
becomes the only source of cellular inositol. It has been reported that the blood brain 
barrier is relatively impermeable to inositol (8), and proposed that, in consequence, 
nerve cells are primarily dependent upon the Li+ sensitive pathways for free inositol. 
Therefore, nerve cells may be particularly vulnerable to the inhibitory action of Li+ 
particularly during periods of intense stimulation, in comparison to peripheral cells 
which are exposed to supplies of inositol in plasma. This behaviour has two interesting 
aspects in relation to the therapeutic action of Li+. First, the time delay before a 
response to Li+ treatment is observed could be accounted for by the reservoir of PI 
available in cells, which has to be depleted before the inhibitory effect of Li+ becomes 
significant. Secondly, the inhibitory effect of Li+ will be significant only in cells when 
the receptors are being hyperstimulated, as might be expected in nerve cells during 
periods of severe mania or depression.
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However, it should be noted that the concentrations of inositol in plasma are 
approximately 50-100|xM whereas in cerebrospinal fluid the concentrations are several 
fold higher, and also, in a number of cell types, a transport mechanism has been 
identified which allows inositol to accumulate in cells against the electrochemical 
gradient (9). Thus, if the rate of inositol uptake is comparable with the stimulated rate 
of PIC activity, the proposed influence of Li+ on the second messenger system may be 
minimal and might not be responsible for the therapeutic action of Li+ in bipolar 
affective disorder.
6 . 1 . 2  Mechanism of Hydrolysis of I(l)P i and Inhibition by Li+
The mechanism of the inhibition of inositol monophosphatase by Li+ was 
confirmed to be uncompetitive ( 10). This type of inhibition of an enzyme is extremely 
rare in nature, and can arise when the inhibitor, 1, binds to the enzyme-substrate 
complex, ES, rather than to the free enzyme, E. In comparison, in competitive 
inhibition, E can combine with either the substrate, S, to give the complex ES, or with 1 
to give El. This type of inhibition usually occurs when 1 is a substrate analogue and 
sits in the active site normally occupied by 1. In competitive inhibition, S and 1 have a 
linear relationship over a wide concentration range - thus the inhibition of E, caused by 
an increase in the concentration of I can be overcome by a proportionate increase in the 
concentration of S. In uncompetitive inhibition however, an increase in the 
concentration of 1 requires a disproportionately large increase in the concentration of S 
to maintain the same metabolic turnover of E, and at higher inhibitor concentrations the 
inhibition may not be overcome at all.
Inositol monophosphatase is completely dependent upon Mg^+ for activity, and 
is competitively inhibited by Ca^+, Mn^+ and myo-inositol 2-phosphate (11); Ca7+ is a 
competitive inhibitor for Mg2+ binding. The inhibition by Li+ is uncompetitive, with 
no evidence that Li+ is competitive with either Mg^+ or l(l)Pi. Through detailed
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kinetic studies on this enzyme, the mechanism of the phosphate ester hydrolysis and tlie 
inhibitory effect of Li+ is being investigated (for a recent review see reference 9 ). The 
hydrolysis of myo-inositol 1-phosphate, as it is currently understood, involves a 
ternary complex mechanism which is summarised in Figure 6.2. The enzyme binds 
the substrate, I(l)Pi, with H2O being the second substrate (step 1 in Figure 6.2) and 
the ester is then hydrolysed to give inositol and P* (step 2 ). Inositol is the first product 
off (step 3 ) with Pi debinding last (step 4 ). The co-factor, Mg2+, appears to bind to 
the enzyme after 1(1 )Pi does, implying that the substrate either modifies, or creates the 
binding site for Mg7+. Mg2+ is only required for the catalytic steps and Li+ binds to 
the active site which vacated by Mg^+ before Pi is released. Li+ can bind to either the 
E:S complex, where it apparently does not prevent inositol from debinding, or to the 
E:Pi complex. In complexation with Li+, the activity of the enzyme is severely 
reduced.
H2O
(1)
E : S : H2O
(2)
|E : 1 : Pj
(5) IK
m
E |  +  IP,
« J  I
Eu-m
(6) iK
E : 1 : Pi : Li+ E : Pi : Li+
Figure 6.2 Postulated mechanism of the hydrolysis of inositol 1-monophosphate,
(S), by inositol 1-monophosphatase, (E), and the interaction by Li+
(1 = inositol. Pi = HPO47-)
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6 . 1 . 3  Structure of Inositol Monophosphatase
Both of the inositol monophosphatases purified from rat brain and from bovine 
brain are homodimers with molecular weights of 55,000 (12) and 58,000 (11), 
respectively. By expression in Escherichia coli, the bovine enzyme has been 
successfully sequenced and cloned (13), and subsequently both the human and rat brain 
inositol monophosphatases have been cloned and purified (14).
The structure of the human inositol monophosphatase, purified from 
Escherichia coli , has recently been determined using X-ray crystallography (15). 
Figure 6.3 is a ribbon representation of the inositol 1-monophosphatase dimer, 
showing the secondary structure of the enzyme. The dimer consists of identical 
subunits, with Gd^+ (orange sphere) and 804 "^ (ball and stick) bound at identical sites 
on each subunit. Gd^+, was employed as a heavy metal substitute for Ca^+, which 
competes with the normal co-factor, Mg^+, and occupies the same position on the 
enzyme as Ca^+ does. Therefore, the position occupied by Gd^+ on the enzyme in this 
crystal structure is probably the active site normally occupied by Mg^+ in vivo. 
Similarly, 804 -^ is expected to interact with the enzyme in the same manner as the 
phosphate group of the substrate or phosphate product of the hydrolysis reaction, and 
therefore the position of 8O4 in the crystal structure is likely to be significant also. 
These active sites appear to sit in a relatively large, and predominantly hydrophilic 
'cavern' within the enzyme, which is much larger than is required to accommodate the 
substrate, l(l)Pi- Knowledge of the structure of the enzyme should now lead to a 
better understanding of the mechanism of the hydrolysis and also to the design of 
inhibitors of the enzyme to confirm (or disprove) that the inhibitory effect of Li+ is 
responsible for its therapeutic action.
134
Figure 6.3 Ribbon Representation of the Secondary Stnicture of the Inositol
Monophosphatase Dimer fi5j.
(Gd^+ is shown as an orange sphere and SO4 is represented by a ball and stick model)
Photograph donated by, and reproduced with the kind permission o f Dr CJ. Ragan, 
Director of Biochemistry at Merck, Sharpe & Dohme Research Laboratories, Harlow,
Essex.
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6.1.5 Changes in Inositol Levels in Human Brain
The study of the phosphoinositide cycle in humans is obviously very limited, 
however in vivo ^Ip-nmr spectroscopy has the potential to explore the concentrations 
of phosphorous metabolites in all human tissue, including the brain. The in vivo 
31p-nmr spectroscopy of the brains of bipolar patients treated with Li+ showed elevated 
levels of phosphomonoesters (PME) in patients in the manic state, compared to those in 
the euthymie state and to Li+-free controls (16). This was believed to be due to 
elevation of the level of I(l)Pi, which is known to appear in this region of the ^Ip-nmr 
spectrum, however, that it could arise from elevation of other substance, such as 
phosphorylethanolamine or phosphorylcholine, could not be ruled out. High- 
resolution 3lp-nmr spectroscopy of the brain extracts of Li+-treated cats had previously 
confirmed that the elevated level of PME observed in the cat brains by in vivo 31p-nmr 
spectroscopy using surface coils, was predominantly due to I(l)Pi (17). Similar 
results have also been reported recently by the in vivo 3lp-nmr spectroscopy of rat 
brain (18).
6 .2  ^L:-Nmr Studies of Interaction of Li+ with Enzymes
The potential of ^Li-nmr spectroscopy as a probe in enzyme studies was 
demonstrated by a study on the cation binding sites of Na+/K+-ATPase (19). By 
substituting Li+ for K+ in the K+ binding site on the enzyme, the ^Li-nuclear relaxation 
rate increased with increasing [Mn^+]. Mn^+, a paramagnetic cation, was used in this 
study as a substitute for Mg^+, which is diamagnetic. The paramagnetic effect upon the 
^Li relaxation rate was used to estimate the distance between the Mn^+ and the Li+ on 
the enzyme, and hence to give information on the distances of the K+ and Mg2+ 
binding sites on the enzyme. No change in Ti was observed on addition of increasing 
amounts of Mg^+ to similar solutions of the enzyme and Li+.
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In the research for this thesis, ^Li-nmr spectroscopy has been employed to 
investigate the interaction of Li+ with the enzyme, inositol 1-monophosphatase. Any 
binding of Li+ to the enzyme was expected to be observable in the ^Li-nmr spectrum. 
The inclusion of a chemical shift reagent in the solution should produce a shift 
difference in the Li-nmr spectrum between the resonances of the two Li+ species (the 
bound and the free aqueous Li+). If the exchange rate between these two species is 
relatively slow (on the NMR timescale), both signals will be observed in the spectrum. 
However, if the exchange rate is rapid, only one signal will be observed at a chemical 
shift intermediate between that of the two separate resonances. The Ti relaxation time 
of the bound Li+ is expected to be considerably shorter than that of the free ion, and tlie 
overall measurable Tj relaxation time of the Li+ resonance in a solution containing the 
enzyme will represent a weighted average of those of the free and bound Li+ species, 
and should, therefore, be significantly lower than that of the Li+ resonance in the 
absence of the enzyme.
6 . 2 .1  ’^ Li-Nmr Studies of the Interaction of Li+ with Inositol
1-Monophosphatase
Aqueous solutions of homogeneous bovine brain inositol 1-monophosphatase, 
containing K+ (250mM), Mg2+ (3mM) and Tris (50mM) at pH 7.5, with varying 
concentrations of LiCl, inositol 1-monophosphate, HPO42-, inositol and Dy(P30io)2^' 
were examined by 70-nmr spectroscopy to investigate the interaction between the 
enzyme and Li+.
Dy(P30io)2^ “ was initially employed to distinguish between the 7Li resonances 
arising from the free Li+ and any Li+ bound to the enzyme. Although the FID's were 
accumulated for long periods of time and with relatively large sweep widths of up to 
50,000Hz, only a single resonance was observed under any condition, in all the 
solutions used.
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Ti measurements were then performed, using the inversion-recovery technique, 
for the Li+ species present in the various solutions. Dy(P30io)2^" was included in the 
buffer to allow relatively rapid data acquisition and the results recorded in Table 6.1 
show a range of Ti's from 185-350ms. A slight decrease in the Ti of approximately 
10% occurred on addition of the enzyme to the Li+-containing buffer, however this was 
probably due to a concentration, or a viscosity, effect rather than to a specific Li+- 
enzyme interaction. This was confirmed by a decrease in the Ti, of approximately 
20%, following the addition of bovine serum albumin (BSA) to the Li+-containing 
buffer. BSA is a protein of similar molecular weight (66,700) to the inositol 
monophosphatase dimer, with no known interaction with Li+ and, therefore binding to 
Li+ is unlikely to produce an effect upon the relaxation behaviour
No correlation was found between the Ti and the concentration of 1(1 )Pi in 
solutions containing Li+ and the enzyme. Similarly, no significant change in Ti was 
observed on the addition of inorganic phosphate. Pi, to the Li+/enzyme mixture 
however in this case, the subsequent addition of inositol produced a reduction in the 
Ti. Since a similar reduction was observed on the addition of inositol to solutions of 
Li+ and BSA, this behaviour was probably due to the significant increase in the 
viscosity of the solution observed upon the addition of inositol.
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Table 6.1 The effect of inositol monophosphatase (E) on the Tj of ^ Li in a variety
Solutes in Buffer* (mM) Ti / ms
Li+(1) 349
Li+(1) + E(0.2) 296
Li+ (l) + E (0.2)+I(l)P i (0.8) 312
Li+ (1) + E (0.2) + I(l)Pi (1.6) 296
Li+ (1) + E (0.2) + I(l)Pi (3.1) 286
Li+ (1) + E (0.2) + I(l)Pi (10.6) 337
Li+ (1) + E (0.3) + Pi§ (10) 339
Li+ (1) + E (0.3) + Pi (10) + inositol (100) 244
Li+ (1) + E (0.3) + Pi (10) + inositol (200) 247
Li+ (1) + E (0.3) + Pi (10) + inositol (400) 238
Li+ (10) 295
Li+ (10) + E (0.4) 268.
Li+ (10)+ E (0.4) + Pi (3) 284
Li+ (10) + E (0.4) + Pi (3) + inositol (200) 244
Li+ (10) + BSAt (0.37) 235
Li+ (10) + BSA (0.37) + inositol (200) 186
Li+(10)) + inositol (200) 258
"buffer = KCl (175mM), MgCl2 (3mM), K5P3O10 (15mM), Tris (50mM) and DyCl3
(ImM) at pH 7.5;
§Pi = inorganic phosphate, K2HPO4; tBSA = bovine serum albumin
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6.3 Discussion
The conditions employed in these studies were selected to optimise the 
possibility of observing a Li+:enzyme interaction. At a Li+ concentration of ImM and 
an enzyme concentration of 0.2mM, it was estimated that approximately 50% of the Li+ 
is likely to be bound to the enzyme. First, the substrate, I(l)Pi, was added to solutions 
of Li+ and the enzyme to force the equilibriums in the forward directions (in Figure
6.2) and then, in similar experiments, the products of the hydrolysis reaction, inositol 
and Pi, were added to force the equilibria in the reverse directions, in order to obtain 
significant levels of the E:I:Pi:Li+ complex and/or the E:Pi:Li+ complex.
The presence of only a single resonance in the Li+/enzyme mixtures on the 
addition of the shift reagent is probably indicative of a relatively fast exchange rate for 
the bound and free Li+ species. However, the reason for the absence of any observable 
effect upon the relaxation behaviour of the Li+ ion is unknown. It may be that the 
effect of the shift reagent, of reducing the Tj of all the Li+ species in these solutions, is 
masking any effect due to a Li+:enzyme interaction. Therefore, these experiments 
should ideally be performed in the absence of Dy(P30io)2 '^» however this would 
impractical due to the extremely long acquisition times that would be required in order 
to obtain adequate signal-to noise in each spectrum. Apart from the disadvantage of 
limited spectrometer availability, the instability of the enzyme preparation, which is 
contaminated with a small amount of a protease, makes this approach unrealistic.
Under all the conditions employed in this study it was not possible to observe 
any interaction between Li+ and inositol 1-monophosphatase.
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Chapter 7
Caesium NMR Spectroscopy of Erythrocytes
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7.1.1 Biological Effects of Cs+
Cs+ is an ultra-trace element in humans, however the biochemistry of this cation 
has not been investigated in any depth. A role for Cs+ in the treatment of depression 
has been reported (1 ). Additionally, a membrane abnormality, or an abnormality in the 
distribution of Cs+ across the erythrocyte membrane, has been postulated to be a 
consequence of alcoholism. The concentration of Cs+ in the serum of patients 
suffering from alcohol dependence syndrome correlated positively with the degree of 
saturation in the fatty acids of the erythrocyte phospholipids (2). This correlation was 
not observed in either healthy controls or in patients suffering from schizophrenia (3). 
Also, the concentration of Cs+ in the erythrocytes of abstinent alcoholic subjects 
(approximately 2.3 ngml"l) was significantly higher than that the erythrocytes of age- 
matched, healthy controls (approximately 1.3 ngml-1) (4). This latter abnormality was 
independent of the length of abstinence, which ranged from 1 day to 5 years, and did 
not appear to be related to liver damage. If these high Cs+ levels are attributable to 
alcohol ingestion, the relatively short lifetime of erythrocytes indicates a long tenu, or 
permanent alcohol-induced abnormality. It may be that this observation could be 
employed as a biological marker for, and may indicate a predisposition to alcohol 
dependence.
7 . 1 . 2  Transport of Cs+ in Biological Systems
Very few studies have been reported on the transport of Cs+ through biological 
membranes. In the systems which have been investigated, the transport of Cs+ into 
cells is sensitive to ouabain inhibition (5,6) and in the absence of extracellular K+, Cs+ 
can activate the Na+/K+-ATPase, being translocated in the process (7). It is probable 
that Cs+ is transported at least in part by the Na+/K+ pump, substituting for, or 
competing with K+, however in general Cs+ is less effective than Rb+ in substituting
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for K+. Cs+ also appears to be able to block the Na+, and the K+ voltage-dependent 
channels in excitable membranes (8).
7 . 1 . 3  I33(2s-Nmr Spectroscopy of Biological Systems
In studies of both human erythrocytes in aqueous suspension and excised rat 
hearts perfused with Cs+-containing medium, it was found that the intra-, and the 
extracellular Cs+ resonances could be distinguished without the use of the paramagnetic 
shift reagents required for the study of other alkali metal ions (6). The study reported 
that the Cs+ species in the suspensions of erythrocytes exhibited 100% nmr-visibility 
and the spin-lattice relaxation times, Ti, for Cs+ were 4.5s in the erythrocytes 
compared to 13.6s in the extracellular buffer, and 2.5 in the rat heart compared to 12s 
in the perfusate. The uptake of Cs+ both into the erythrocytes and into the perfused 
heart was monitored with respect to time. The observed inhibition of uptake in 
erythrocytes due to the presence of ouabain was comparable to the ouabain-inhibited 
uptake of K+ or Rb+, implying that Cs+ is transported into erythrocytes via an active 
transport pathway that is very similar to, or is the same as a specific K+ transporter.
A detailed investigation of the intracellular Cs+, and the effects of various shift 
reagents upon the chemical shifts of the extracellular Cs+ resonances in the i33Cs-nmr 
spectra of erythrocyte suspensions have been reported (9). The resolution of the intra-, 
and the extracellular Cs+ signals in the absence of a shift reagent was ascribed to the 
interactions of Cs+ with the intracellular phosphates, in particular 2,3- 
diphosphoglycerate (DPG), in which a 1:1 complex is formed with DPG acting as a 
tridentate ligand.
133cs-nmr spectroscopy has also been employed to study subcellular 
compartmentation and ion uptake in perfused maize seedling roots (10). Without 
incorporating a shift reagent, 3 resonances were observed in the spectra obtained and
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these were assigned to Cs+ in the perfusate, and to Cs+ in the cytoplasm and the 
vacuole of the maize root cells. The uptake of Cs+ into the 2 pools was monitored with 
respect to time.
The ionophore-induced transport of Cs+ across membranes has been 
investigated in phospholipid vesicles, using the PaOio^" anion to generate a chemical 
shift difference between the intra-, and the extracellular Cs+ resonances (11). In 
contrast to studies on other alkali metal ions, no paramagnetic lanthanide was requked 
and the observed shift difference was attributed to the different anionic compositions of 
the intra-, and the extracellular fluids. The ionophore employed was nigericin, an 
efficient ionophore for the transport of K+.
7 .2  Nmr Study of Cs+ Transport in Human Erythrocytes
Following the observation of elevated Cs+ levels in the erythrocytes of patients 
suffering from alcohol-dependence syndrome, and the postulate of an abnormality in 
the transport of Cs+ transport and/or in the trans-membrane distribution of Cs+ the 
transport of Cs+ in erythrocytes of healthy controls and of alcoholic individuals was 
investigated by ^^SCs-nmr spectroscopy.
7 . 2 . 1  i^^Cs-Nmr Spectroscopy of Erythrocytes
The uptake of Cs+ into human erythrocytes was monitored in vitro by isolating 
erythrocytes from whole blood and resuspending them at 37“C in an isotonic medium 
containing lOmM Cs+. After the determination of the 90“ pulse width and the Ti 
values for the different Cs+ species, the intracellular concentrations were determined by 
quantitative ^^^Cs-nmr spectroscopy, using the same method employed for Li+ in 
Chapter 3.
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The suspension medium employed, containing no shift reagent, (see Section
2.7.2) produced a shift difference of typically l.lppm between the intra-, and the 
extracellular Cs+ resonances. The Ti's were 3.38 ± 0.03s and 11.24 ± 0.15s for the 
intra-, and the extracellular Cs+ resonances, respectively. These compare with reported 
Ti's of 4.5s and 13.6s for erythrocytes incubated in a different suspension medium
(6). Therefore an interpulse delay of 60s (i.e. > 5 x T%) was employed to ensure 
complete relaxation of both Cs+ species, and thus valid quantification of the [Cs+]in-
7 . 2 . 2  l^^Cs-Nmr Spectroscopy of Erythrocytes from Healthy
Controls and Patients Suffering from Alcohol-Dependence 
Syndrome
The uptake of Cs+ into the erythrocytes of 2 abstinent, healthy volunteers was 
monitored with respect to time. These people had never previously imbibed alcohol, as 
far as they were aware. Figure 7.1 shows a series of l33Cs-nmr spectra from a typical 
experiment. The spectra show two signals, one at -1.09ppm assigned to the 
extracellular Cs+ (COi/2 = 13Hz) and one at Oppm assigned to the intracellular Cs+ 
(0 )1/2 = 19Hz).
This experiment was then repeated several times with erythrocytes from a 
number of healthy individuals, who were neither abstinent nor alcohol-dependent, and 
with erythrocytes from a number of patients suffering from alcohol-dependence 
syndrome. In all cases the results were very similar. The time dependence of the 
[Cs+]in from 2 typical experiments, 1 on an abstinent control and 1 on an alcoholic 
patient, is illustrated in Figure 7.2. In both cases, the uptake is approximately linear 
over the time period studied (8h) and the rate is approximately 0.33mM h"i, with no 
evidence for saturation.
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[Cs+]in/mM Incubation Time /min.
3391.965
1541.050
0.741
-6- 44 2 0 -2PPM
Figure 7,1 spectra of human erythrocytes incubated in phosphate buffer
containing lOmM Cs+, showing time dependence of the intracellular [Cs+]
(Each spectrum is the sum of 8 acquisitions recorded at 66MHz on the MSL500 nmr
spectrometer)
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Incubation of erythrocytes in the suspension medium (lOmM Cs+, 24h, 37“C, 
4% haematocrit) resulted in an intracellular [Cs+] of approximately 5mM. The efflux of 
Cs+ from the Cs+-loaded erythrocytes was monitored by resuspending the erythrocytes 
in Cs+-free isotonic medium at 37“C for up to 8h, however under these conditions, no 
reduction in the intracellular [Cs+] was observed.
The effect of extracellular Cs+ on the intracellular concentrations of Na+ and K+ 
was investigated by ^^Na- and ^9K-nmr spectroscopy, by substituting Na+ for Cs+ in 
the extracellular medium. Although the absolute values should be treated with caution 
since the effects of nmr invisibility have not been taken into account, the changes in the 
intracellular levels of these cations are illustrated in Figure 7.3. As expected, the 
[Cs+]in increases with increasing [Cs+]out- A slight decrease in the [Na+]m is observed 
with increasing [Cs+]out> although this is probably due to the efflux of Na+ from the 
erythrocytes as a result of the significant reduction in [Na+]out- More interesting is the 
considerable reduction in [K+]in with increasing [Cs+]out» despite the fact that the 
[K+]out remains constant.
0 100 500200 300 400
—  a — ControlPatient
Incubation Period /min.
Figure 7.2 The uptake of Cs+ into the erythrocytes of an abstinent healthy control 
and a patient suffering from alcohol-dependence syndrome, at [Cs+]out of lOmM
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Figure 7.3 The effect increasing the extracellular [Cs+] on the intracellular [Cs+], 
[Na+] and [K+] in suspensions of human erythrocytes
7 .3 Discussion
I33cs-nmr spectroscopy is aided by the fact that the natural abundance of l33Cs 
is 100% and that the chemical shifts of Cs+ are more anion dependent than those of the 
other alkali metal ions, because of the larger ionic radius of this cation.
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The resolution of the intra-, and the extracellular Cs+ resonances was achieved 
without the incorporation of a chemical shift reagent as expected from a previous study 
{6). The linear uptake of Cs+ occurred at a rate of 0.33mMh"^ which is approximately 
half that previously observed in a study which employed the same [Cs+]out but which 
used a different suspension medium, not containing K*'(6). Since it is likely that the 
uptake of Cs+ is, at least in part, mediated by a K+ transport mechanism (6,7), the 
presence of K+ in the suspension medium employed in this study, is probably 
responsible for the lower uptake rate, with Cs+ in competition with K+ for the 
transporter. The decrease in the intracellular concentration of K+ as the concentration 
of the extra-, and consequently the intracellular Cs+ increases, confirms that Cs+ can 
behave as a substitute for K+ in erythrocytes. It appears that there is no effective efflux 
mechanism available for the transport of Cs+ out of erythrocytes as indicated by the 
absence of efflux from the Cs+-loaded cells.
Interestingly, the uptake of Cs+ into erythrocytes from completely abstinent 
healthy controls was virtually identical to that from the alcoholic patients, indicating a 
lack of transport abnormality under these concentrations and conditions. However, it 
should be noted that Cs+ is only an ultra-trace element in humans, a level of 1.3ngml'l 
has been quoted for the concentration of Cs+ in the erythrocytes of healthy individuals 
(4), and the transport of Cs+ at endogenous concentrations may well be completely 
different from the relatively high concentration employed in this study (lOmM). 
Unfortunately, the relative insensitivity of nmr spectroscopy means that transport 
studies at physiological concentrations are impossible by this technique.
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